DE69635231T2 - Selektive Inhibitoren viraler oder bakterieller Neuraminidase - Google Patents
Selektive Inhibitoren viraler oder bakterieller Neuraminidase Download PDFInfo
- Publication number
- DE69635231T2 DE69635231T2 DE69635231T DE69635231T DE69635231T2 DE 69635231 T2 DE69635231 T2 DE 69635231T2 DE 69635231 T DE69635231 T DE 69635231T DE 69635231 T DE69635231 T DE 69635231T DE 69635231 T2 DE69635231 T2 DE 69635231T2
- Authority
- DE
- Germany
- Prior art keywords
- compound
- mmol
- nitro
- solution
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108010006232 Neuraminidase Proteins 0.000 title claims abstract description 37
- 102000005348 Neuraminidase Human genes 0.000 title claims abstract description 36
- 230000001580 bacterial effect Effects 0.000 title description 3
- 230000003612 virological effect Effects 0.000 title description 3
- 229940124639 Selective inhibitor Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 419
- 238000000034 method Methods 0.000 claims abstract description 225
- -1 antibodies Substances 0.000 claims abstract description 84
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 20
- 230000000694 effects Effects 0.000 claims abstract description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 8
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims description 37
- 238000011282 treatment Methods 0.000 claims description 24
- 150000003839 salts Chemical class 0.000 claims description 19
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 206010022000 influenza Diseases 0.000 claims description 6
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 5
- 238000011321 prophylaxis Methods 0.000 claims description 5
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000012453 solvate Substances 0.000 claims description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 abstract description 50
- 229920000642 polymer Polymers 0.000 abstract description 13
- 239000003112 inhibitor Substances 0.000 abstract description 4
- 238000003556 assay Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 327
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 225
- 239000000243 solution Substances 0.000 description 160
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 138
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 128
- 235000019439 ethyl acetate Nutrition 0.000 description 125
- 238000006243 chemical reaction Methods 0.000 description 124
- 239000000203 mixture Substances 0.000 description 124
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 120
- 238000005160 1H NMR spectroscopy Methods 0.000 description 102
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 99
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 97
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 87
- 239000007787 solid Substances 0.000 description 76
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 71
- 235000019441 ethanol Nutrition 0.000 description 70
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 68
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 64
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 60
- 238000003818 flash chromatography Methods 0.000 description 55
- 239000002904 solvent Substances 0.000 description 54
- 150000001412 amines Chemical class 0.000 description 52
- 239000000047 product Substances 0.000 description 51
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 50
- 239000012267 brine Substances 0.000 description 49
- 230000008569 process Effects 0.000 description 47
- 239000000741 silica gel Substances 0.000 description 47
- 229910002027 silica gel Inorganic materials 0.000 description 47
- 235000001014 amino acid Nutrition 0.000 description 45
- 229940024606 amino acid Drugs 0.000 description 45
- 239000002253 acid Substances 0.000 description 44
- 238000000746 purification Methods 0.000 description 44
- 150000001413 amino acids Chemical class 0.000 description 43
- 229920005989 resin Polymers 0.000 description 43
- 239000011347 resin Substances 0.000 description 43
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 42
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 42
- 239000003153 chemical reaction reagent Substances 0.000 description 41
- 150000001540 azides Chemical class 0.000 description 40
- 239000011541 reaction mixture Substances 0.000 description 39
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 36
- 239000002585 base Substances 0.000 description 35
- 230000003213 activating effect Effects 0.000 description 33
- 239000003921 oil Substances 0.000 description 33
- 235000019198 oils Nutrition 0.000 description 32
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 32
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 30
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- 230000015572 biosynthetic process Effects 0.000 description 30
- 239000000543 intermediate Substances 0.000 description 30
- 238000009472 formulation Methods 0.000 description 29
- 239000003054 catalyst Substances 0.000 description 27
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 26
- 239000004480 active ingredient Substances 0.000 description 26
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 26
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 25
- 239000003480 eluent Substances 0.000 description 25
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 25
- 238000003786 synthesis reaction Methods 0.000 description 25
- 239000000126 substance Substances 0.000 description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 23
- 238000003756 stirring Methods 0.000 description 23
- 150000002009 diols Chemical class 0.000 description 22
- 150000002148 esters Chemical class 0.000 description 22
- 125000006239 protecting group Chemical group 0.000 description 22
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 22
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 21
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 20
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 20
- 239000012044 organic layer Substances 0.000 description 20
- 230000002829 reductive effect Effects 0.000 description 20
- 229920001429 chelating resin Polymers 0.000 description 19
- 238000006467 substitution reaction Methods 0.000 description 18
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 18
- 239000012043 crude product Substances 0.000 description 17
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 239000012074 organic phase Substances 0.000 description 16
- 150000002924 oxiranes Chemical class 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 230000004913 activation Effects 0.000 description 15
- 238000001994 activation Methods 0.000 description 15
- 239000003638 chemical reducing agent Substances 0.000 description 15
- 150000004702 methyl esters Chemical class 0.000 description 15
- 230000009467 reduction Effects 0.000 description 15
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 14
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 14
- 239000000284 extract Substances 0.000 description 14
- 230000002163 immunogen Effects 0.000 description 14
- 230000009466 transformation Effects 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 13
- 239000006260 foam Substances 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 12
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 12
- 239000012038 nucleophile Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 12
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 12
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 11
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 11
- 239000002207 metabolite Substances 0.000 description 11
- 239000012071 phase Substances 0.000 description 11
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 11
- 229920006395 saturated elastomer Polymers 0.000 description 11
- 239000000725 suspension Substances 0.000 description 11
- SKMKJBYBPYBDMN-RYUDHWBXSA-N 3-(difluoromethoxy)-5-[2-(3,3-difluoropyrrolidin-1-yl)-6-[(1s,4s)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrimidin-4-yl]pyridin-2-amine Chemical compound C1=C(OC(F)F)C(N)=NC=C1C1=CC(N2[C@H]3C[C@H](OC3)C2)=NC(N2CC(F)(F)CC2)=N1 SKMKJBYBPYBDMN-RYUDHWBXSA-N 0.000 description 10
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 10
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 10
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 10
- 125000003277 amino group Chemical group 0.000 description 10
- 235000019270 ammonium chloride Nutrition 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- 229920001184 polypeptide Polymers 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- 239000007858 starting material Substances 0.000 description 10
- 238000012546 transfer Methods 0.000 description 10
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 9
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 9
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 9
- 230000003197 catalytic effect Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 238000001704 evaporation Methods 0.000 description 9
- 230000008020 evaporation Effects 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 230000007062 hydrolysis Effects 0.000 description 9
- 238000006460 hydrolysis reaction Methods 0.000 description 9
- 238000001727 in vivo Methods 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 150000002596 lactones Chemical class 0.000 description 9
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 150000003335 secondary amines Chemical class 0.000 description 9
- JSPLKZUTYZBBKA-UHFFFAOYSA-N trioxidane Chemical compound OOO JSPLKZUTYZBBKA-UHFFFAOYSA-N 0.000 description 9
- VGVSQCOSLXVVHM-UHFFFAOYSA-N 1-tritylaziridine Chemical compound C1CN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 VGVSQCOSLXVVHM-UHFFFAOYSA-N 0.000 description 8
- 0 CCCO[C@@]([C@@](*)[C@@](C1)N)C=C1C(OC)=O Chemical compound CCCO[C@@]([C@@](*)[C@@](C1)N)C=C1C(OC)=O 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 8
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 8
- 150000001336 alkenes Chemical class 0.000 description 8
- 150000001408 amides Chemical class 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- 229910052786 argon Inorganic materials 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 125000004494 ethyl ester group Chemical group 0.000 description 8
- 239000011981 lindlar catalyst Substances 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 7
- 239000012346 acetyl chloride Substances 0.000 description 7
- 239000002168 alkylating agent Substances 0.000 description 7
- 229940100198 alkylating agent Drugs 0.000 description 7
- 239000000010 aprotic solvent Substances 0.000 description 7
- 239000012298 atmosphere Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 7
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 7
- CSOJECDGWHHWRS-UHFFFAOYSA-N tert-butyl n-[(2-methylpropan-2-yl)oxycarbonylcarbamothioyl]carbamate Chemical compound CC(C)(C)OC(=O)NC(=S)NC(=O)OC(C)(C)C CSOJECDGWHHWRS-UHFFFAOYSA-N 0.000 description 7
- 238000000844 transformation Methods 0.000 description 7
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 6
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000003377 acid catalyst Substances 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 125000003158 alcohol group Chemical group 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 6
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 6
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 5
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 108090000288 Glycoproteins Proteins 0.000 description 5
- 102000003886 Glycoproteins Human genes 0.000 description 5
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 150000001299 aldehydes Chemical class 0.000 description 5
- ICCBZGUDUOMNOF-UHFFFAOYSA-N azidoamine Chemical compound NN=[N+]=[N-] ICCBZGUDUOMNOF-UHFFFAOYSA-N 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 238000004132 cross linking Methods 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 150000005690 diesters Chemical class 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 150000004820 halides Chemical class 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000003456 ion exchange resin Substances 0.000 description 5
- 229920003303 ion-exchange polymer Polymers 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 150000002825 nitriles Chemical class 0.000 description 5
- 239000003586 protic polar solvent Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 241000712461 unidentified influenza virus Species 0.000 description 5
- 239000003039 volatile agent Substances 0.000 description 5
- 238000010626 work up procedure Methods 0.000 description 5
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 4
- NRKYWOKHZRQRJR-UHFFFAOYSA-N 2,2,2-trifluoroacetamide Chemical compound NC(=O)C(F)(F)F NRKYWOKHZRQRJR-UHFFFAOYSA-N 0.000 description 4
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 150000001350 alkyl halides Chemical class 0.000 description 4
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 4
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
- 230000001588 bifunctional effect Effects 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 229940125904 compound 1 Drugs 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 229940042406 direct acting antivirals neuraminidase inhibitors Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 150000003840 hydrochlorides Chemical class 0.000 description 4
- 150000002440 hydroxy compounds Chemical class 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 150000004714 phosphonium salts Chemical class 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 239000002911 sialidase inhibitor Substances 0.000 description 4
- 229910000104 sodium hydride Inorganic materials 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 4
- RFABHELHVJVEPO-UHFFFAOYSA-N 1-nitrooctan-3-ol Chemical compound CCCCCC(O)CC[N+]([O-])=O RFABHELHVJVEPO-UHFFFAOYSA-N 0.000 description 3
- IQNHBUQSOSYAJU-UHFFFAOYSA-N 2,2,2-trifluoro-n-methylacetamide Chemical compound CNC(=O)C(F)(F)F IQNHBUQSOSYAJU-UHFFFAOYSA-N 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N 2-butanol Substances CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- KJTQHXTUICAYHG-UHFFFAOYSA-N 3-methyl-1-nitrobutan-2-ol Chemical compound CC(C)C(O)C[N+]([O-])=O KJTQHXTUICAYHG-UHFFFAOYSA-N 0.000 description 3
- MVFMATZFWFEEKJ-UHFFFAOYSA-N 3-methyl-3-nitrobutan-2-ol Chemical compound CC(O)C(C)(C)[N+]([O-])=O MVFMATZFWFEEKJ-UHFFFAOYSA-N 0.000 description 3
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 3
- OFEODFOGZSJOCW-UHFFFAOYSA-N 4-methyl-1-nitropentan-2-ol Chemical compound CC(C)CC(O)C[N+]([O-])=O OFEODFOGZSJOCW-UHFFFAOYSA-N 0.000 description 3
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 3
- 150000001241 acetals Chemical class 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 230000037029 cross reaction Effects 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 229910000000 metal hydroxide Inorganic materials 0.000 description 3
- 150000004692 metal hydroxides Chemical class 0.000 description 3
- NSPJNIDYTSSIIY-UHFFFAOYSA-N methoxy(methoxymethoxy)methane Chemical compound COCOCOC NSPJNIDYTSSIIY-UHFFFAOYSA-N 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 238000007142 ring opening reaction Methods 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 150000003459 sulfonic acid esters Chemical class 0.000 description 3
- VPWFNCFRPQFWGS-UHFFFAOYSA-N tert-butyl n-[amino-[(2-methylpropan-2-yl)oxycarbonylamino]methylidene]carbamate Chemical compound CC(C)(C)OC(=O)NC(N)=NC(=O)OC(C)(C)C VPWFNCFRPQFWGS-UHFFFAOYSA-N 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 2
- KLGNQHRPPLDIFC-MRVPVSSYSA-N (2r)-1-fluorooctan-2-ol Chemical compound CCCCCC[C@@H](O)CF KLGNQHRPPLDIFC-MRVPVSSYSA-N 0.000 description 2
- KJTQHXTUICAYHG-YFKPBYRVSA-N (2r)-3-methyl-1-nitrobutan-2-ol Chemical compound CC(C)[C@@H](O)C[N+]([O-])=O KJTQHXTUICAYHG-YFKPBYRVSA-N 0.000 description 2
- MVFMATZFWFEEKJ-SCSAIBSYSA-N (2r)-3-methyl-3-nitrobutan-2-ol Chemical compound C[C@@H](O)C(C)(C)[N+]([O-])=O MVFMATZFWFEEKJ-SCSAIBSYSA-N 0.000 description 2
- YSAZHINBXCWZTE-SCSAIBSYSA-N (3R)-3-fluorobutan-1-ol Chemical compound C[C@@H](F)CCO YSAZHINBXCWZTE-SCSAIBSYSA-N 0.000 description 2
- OTIXUSNHAKOJBX-UHFFFAOYSA-N 1-(aziridin-1-yl)ethanone Chemical compound CC(=O)N1CC1 OTIXUSNHAKOJBX-UHFFFAOYSA-N 0.000 description 2
- GVEMIUUOJFZCOD-UHFFFAOYSA-N 1-fluoro-2-methylpropan-2-ol Chemical compound CC(C)(O)CF GVEMIUUOJFZCOD-UHFFFAOYSA-N 0.000 description 2
- SBUDCAVGUUUDNE-UHFFFAOYSA-N 1-fluoro-3,3-dimethylbutan-2-ol Chemical compound CC(C)(C)C(O)CF SBUDCAVGUUUDNE-UHFFFAOYSA-N 0.000 description 2
- MPGNSGYTEYWFIS-UHFFFAOYSA-N 1-fluorobutan-2-ol Chemical compound CCC(O)CF MPGNSGYTEYWFIS-UHFFFAOYSA-N 0.000 description 2
- KLGNQHRPPLDIFC-UHFFFAOYSA-N 1-fluorooctan-2-ol Chemical compound CCCCCCC(O)CF KLGNQHRPPLDIFC-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FMEFHKJRIGHSLB-UHFFFAOYSA-N 1-nitrobutan-2-ol Chemical compound CCC(O)C[N+]([O-])=O FMEFHKJRIGHSLB-UHFFFAOYSA-N 0.000 description 2
- ZSOIKNVZUIEXAQ-UHFFFAOYSA-N 1-nitrododecan-2-ol Chemical compound CCCCCCCCCCC(O)C[N+]([O-])=O ZSOIKNVZUIEXAQ-UHFFFAOYSA-N 0.000 description 2
- VJCZJBJUAGHLEY-UHFFFAOYSA-N 1-nitroheptan-2-ol Chemical compound CCCCCC(O)C[N+]([O-])=O VJCZJBJUAGHLEY-UHFFFAOYSA-N 0.000 description 2
- UHUZCPVKBAPSSA-UHFFFAOYSA-N 1-nitrooctan-2-ol Chemical compound CCCCCCC(O)C[N+]([O-])=O UHUZCPVKBAPSSA-UHFFFAOYSA-N 0.000 description 2
- ACNMOTQCLBFDMQ-UHFFFAOYSA-N 1-nitropentan-2-ol Chemical compound CCCC(O)C[N+]([O-])=O ACNMOTQCLBFDMQ-UHFFFAOYSA-N 0.000 description 2
- MEGBNFNBKNPNQO-UHFFFAOYSA-N 10-fluorodecan-1-ol Chemical compound OCCCCCCCCCCF MEGBNFNBKNPNQO-UHFFFAOYSA-N 0.000 description 2
- BXNOMEIWVVVPOM-UHFFFAOYSA-N 11-fluoro-2-methylundecan-1-ol Chemical compound OCC(C)CCCCCCCCCF BXNOMEIWVVVPOM-UHFFFAOYSA-N 0.000 description 2
- DWUQJEHGOSZXLO-UHFFFAOYSA-N 11-fluoroundecan-1-ol Chemical compound OCCCCCCCCCCCF DWUQJEHGOSZXLO-UHFFFAOYSA-N 0.000 description 2
- NVMYVARFCPAXNR-UHFFFAOYSA-N 11-fluoroundecan-2-ol Chemical compound CC(O)CCCCCCCCCF NVMYVARFCPAXNR-UHFFFAOYSA-N 0.000 description 2
- PSXISJYLVGWDJC-UHFFFAOYSA-N 11-nitroundecan-1-ol Chemical compound OCCCCCCCCCCC[N+]([O-])=O PSXISJYLVGWDJC-UHFFFAOYSA-N 0.000 description 2
- DRHUCRLKSMPHDB-UHFFFAOYSA-N 12-fluorododecan-1-ol Chemical compound OCCCCCCCCCCCCF DRHUCRLKSMPHDB-UHFFFAOYSA-N 0.000 description 2
- FKLFIROEVCJXIF-UHFFFAOYSA-N 12-nitrododecan-1-ol Chemical compound OCCCCCCCCCCCC[N+]([O-])=O FKLFIROEVCJXIF-UHFFFAOYSA-N 0.000 description 2
- LQMAGZIWFASHJM-UHFFFAOYSA-N 2-fluoro-2-methylpentan-3-ol Chemical compound CCC(O)C(C)(C)F LQMAGZIWFASHJM-UHFFFAOYSA-N 0.000 description 2
- VQDNMKWCOYVVJH-UHFFFAOYSA-N 2-fluoro-2-methylpropan-1-ol Chemical compound CC(C)(F)CO VQDNMKWCOYVVJH-UHFFFAOYSA-N 0.000 description 2
- BLYSPQXGKZNMJA-UHFFFAOYSA-N 2-fluorobutan-1-ol Chemical compound CCC(F)CO BLYSPQXGKZNMJA-UHFFFAOYSA-N 0.000 description 2
- SJZQQJOIMGMRKP-UHFFFAOYSA-N 2-fluorodecan-1-ol Chemical compound CCCCCCCCC(F)CO SJZQQJOIMGMRKP-UHFFFAOYSA-N 0.000 description 2
- PYMZAXRFSIFPKK-UHFFFAOYSA-N 2-fluorododecan-1-ol Chemical compound CCCCCCCCCCC(F)CO PYMZAXRFSIFPKK-UHFFFAOYSA-N 0.000 description 2
- PXUHUAWWMDRECM-UHFFFAOYSA-N 2-fluorooctan-1-ol Chemical compound CCCCCCC(F)CO PXUHUAWWMDRECM-UHFFFAOYSA-N 0.000 description 2
- BFXVQEIWGOVPRX-UHFFFAOYSA-N 2-methyl-1-nitrobutan-2-ol Chemical compound CCC(C)(O)C[N+]([O-])=O BFXVQEIWGOVPRX-UHFFFAOYSA-N 0.000 description 2
- FOOMQHQMUGNBKK-UHFFFAOYSA-N 2-methyl-1-nitropropan-2-ol Chemical compound CC(C)(O)C[N+]([O-])=O FOOMQHQMUGNBKK-UHFFFAOYSA-N 0.000 description 2
- SEAMRWZKMYUKOI-UHFFFAOYSA-N 2-methyl-2-nitrobutan-1-ol Chemical compound CCC(C)(CO)[N+]([O-])=O SEAMRWZKMYUKOI-UHFFFAOYSA-N 0.000 description 2
- AUTNNBNYALYGCQ-UHFFFAOYSA-N 2-methyl-2-nitrohexan-3-ol Chemical compound CCCC(O)C(C)(C)[N+]([O-])=O AUTNNBNYALYGCQ-UHFFFAOYSA-N 0.000 description 2
- XGIVOZBEDLLCCO-UHFFFAOYSA-N 2-methyl-2-nitropentan-3-ol Chemical compound CCC(O)C(C)(C)[N+]([O-])=O XGIVOZBEDLLCCO-UHFFFAOYSA-N 0.000 description 2
- MVGJRISPEUZYAQ-UHFFFAOYSA-N 2-methyl-2-nitropropan-1-ol Chemical compound OCC(C)(C)[N+]([O-])=O MVGJRISPEUZYAQ-UHFFFAOYSA-N 0.000 description 2
- PQGVSRLIQXRYMV-UHFFFAOYSA-N 2-methyl-3-nitropentan-2-ol Chemical compound CCC([N+]([O-])=O)C(C)(C)O PQGVSRLIQXRYMV-UHFFFAOYSA-N 0.000 description 2
- XYQFGZBXVWWGRK-UHFFFAOYSA-N 2-methyl-4-nitrobutan-2-ol Chemical compound CC(C)(O)CC[N+]([O-])=O XYQFGZBXVWWGRK-UHFFFAOYSA-N 0.000 description 2
- WTRFXBIPCREZQA-UHFFFAOYSA-N 2-methyl-4-nitrohexan-3-ol Chemical compound CCC([N+]([O-])=O)C(O)C(C)C WTRFXBIPCREZQA-UHFFFAOYSA-N 0.000 description 2
- LOCQZPLNYZAZHO-UHFFFAOYSA-N 2-methyl-4-nitropentan-3-ol Chemical compound CC(C)C(O)C(C)[N+]([O-])=O LOCQZPLNYZAZHO-UHFFFAOYSA-N 0.000 description 2
- HGGBYJGRYRWRBE-UHFFFAOYSA-N 2-methyl-5-nitropentan-2-ol Chemical compound CC(C)(O)CCC[N+]([O-])=O HGGBYJGRYRWRBE-UHFFFAOYSA-N 0.000 description 2
- MHIHRIPETCJEMQ-UHFFFAOYSA-N 2-nitrobutan-1-ol Chemical compound CCC(CO)[N+]([O-])=O MHIHRIPETCJEMQ-UHFFFAOYSA-N 0.000 description 2
- UIKBCINGVAVLOY-UHFFFAOYSA-N 2-nitrododecan-1-ol Chemical compound CCCCCCCCCCC(CO)[N+]([O-])=O UIKBCINGVAVLOY-UHFFFAOYSA-N 0.000 description 2
- BJKHKPOTYLELSH-UHFFFAOYSA-N 2-nitroheptan-3-ol Chemical compound CCCCC(O)C(C)[N+]([O-])=O BJKHKPOTYLELSH-UHFFFAOYSA-N 0.000 description 2
- PCFLNKSZNBPQOP-UHFFFAOYSA-N 2-nitrohexan-3-ol Chemical compound CCCC(O)C(C)[N+]([O-])=O PCFLNKSZNBPQOP-UHFFFAOYSA-N 0.000 description 2
- UCBZLXDOJPRPPV-UHFFFAOYSA-N 2-nitrooctan-1-ol Chemical compound CCCCCCC(CO)[N+]([O-])=O UCBZLXDOJPRPPV-UHFFFAOYSA-N 0.000 description 2
- OYHTVILGINELNJ-UHFFFAOYSA-N 2-nitropentan-1-ol Chemical compound CCCC(CO)[N+]([O-])=O OYHTVILGINELNJ-UHFFFAOYSA-N 0.000 description 2
- UQCZRXRWSNMZEP-UHFFFAOYSA-N 2-nitropentan-3-ol Chemical compound CCC(O)C(C)[N+]([O-])=O UQCZRXRWSNMZEP-UHFFFAOYSA-N 0.000 description 2
- POPUCNRCMDNMTD-UHFFFAOYSA-N 3,3-dimethyl-1-nitrobutan-2-ol Chemical compound CC(C)(C)C(O)C[N+]([O-])=O POPUCNRCMDNMTD-UHFFFAOYSA-N 0.000 description 2
- CFOIQWACFNTMNS-UHFFFAOYSA-N 3-fluoro-2,3-dimethylbutan-2-ol Chemical compound CC(C)(O)C(C)(C)F CFOIQWACFNTMNS-UHFFFAOYSA-N 0.000 description 2
- YSAZHINBXCWZTE-UHFFFAOYSA-N 3-fluorobutan-1-ol Chemical compound CC(F)CCO YSAZHINBXCWZTE-UHFFFAOYSA-N 0.000 description 2
- DMIRKUOHEBAINR-UHFFFAOYSA-N 3-methyl-2-nitrobutan-1-ol Chemical compound CC(C)C(CO)[N+]([O-])=O DMIRKUOHEBAINR-UHFFFAOYSA-N 0.000 description 2
- CHOTTWGZEKCPHA-UHFFFAOYSA-N 3-nitro-2-pentanol Chemical compound CCC(C(C)O)[N+]([O-])=O CHOTTWGZEKCPHA-UHFFFAOYSA-N 0.000 description 2
- OJVOGABFNZDOOZ-UHFFFAOYSA-N 3-nitrobutan-2-ol Chemical compound CC(O)C(C)[N+]([O-])=O OJVOGABFNZDOOZ-UHFFFAOYSA-N 0.000 description 2
- CVOIQJVZYQYMBH-UHFFFAOYSA-N 3-nitroheptan-4-ol Chemical compound CCCC(O)C(CC)[N+]([O-])=O CVOIQJVZYQYMBH-UHFFFAOYSA-N 0.000 description 2
- DUOURUCKSSLFRF-UHFFFAOYSA-N 4-fluoro-4-methylpentan-2-ol Chemical compound CC(O)CC(C)(C)F DUOURUCKSSLFRF-UHFFFAOYSA-N 0.000 description 2
- SHOBGSRUFRALBO-UHFFFAOYSA-N 4-fluorobutan-1-ol Chemical compound OCCCCF SHOBGSRUFRALBO-UHFFFAOYSA-N 0.000 description 2
- PEAJLEGVRQOZNV-UHFFFAOYSA-N 4-fluorobutan-2-ol Chemical compound CC(O)CCF PEAJLEGVRQOZNV-UHFFFAOYSA-N 0.000 description 2
- DBYMNHYVMTWSLQ-UHFFFAOYSA-N 4-methyl-4-nitropentan-1-ol Chemical compound [O-][N+](=O)C(C)(C)CCCO DBYMNHYVMTWSLQ-UHFFFAOYSA-N 0.000 description 2
- XSOWARLVOQBBOO-UHFFFAOYSA-N 4-nitrobutan-1-ol Chemical compound OCCCC[N+]([O-])=O XSOWARLVOQBBOO-UHFFFAOYSA-N 0.000 description 2
- WYKTYEIIRULHNQ-UHFFFAOYSA-N 4-nitrobutan-2-ol Chemical compound CC(O)CC[N+]([O-])=O WYKTYEIIRULHNQ-UHFFFAOYSA-N 0.000 description 2
- OMUHFGMZLLRVEN-UHFFFAOYSA-N 4-nitroheptan-3-ol Chemical compound CCCC([N+]([O-])=O)C(O)CC OMUHFGMZLLRVEN-UHFFFAOYSA-N 0.000 description 2
- XIXNQTGGBNDDMJ-UHFFFAOYSA-N 4-nitrohexan-3-ol Chemical compound CCC(O)C(CC)[N+]([O-])=O XIXNQTGGBNDDMJ-UHFFFAOYSA-N 0.000 description 2
- UEZJJZXNTWFPBP-UHFFFAOYSA-N 5-fluoro-2-methylpentan-2-ol Chemical compound CC(C)(O)CCCF UEZJJZXNTWFPBP-UHFFFAOYSA-N 0.000 description 2
- FQBZGBYYKHMJFU-UHFFFAOYSA-N 5-fluoropentan-1-ol Chemical compound OCCCCCF FQBZGBYYKHMJFU-UHFFFAOYSA-N 0.000 description 2
- RCIXPUGUGPXKBZ-UHFFFAOYSA-N 5-fluoropentan-2-ol Chemical compound CC(O)CCCF RCIXPUGUGPXKBZ-UHFFFAOYSA-N 0.000 description 2
- JHAZSFLGWSANGV-UHFFFAOYSA-N 5-methyl-5-nitrohexan-2-ol Chemical compound CC(O)CCC(C)(C)[N+]([O-])=O JHAZSFLGWSANGV-UHFFFAOYSA-N 0.000 description 2
- SEICGYRRALKKBW-UHFFFAOYSA-N 5-nitrooctan-4-ol Chemical compound CCCC(O)C([N+]([O-])=O)CCC SEICGYRRALKKBW-UHFFFAOYSA-N 0.000 description 2
- UISXXYURSRKYST-UHFFFAOYSA-N 5-nitropentan-1-ol Chemical compound OCCCCC[N+]([O-])=O UISXXYURSRKYST-UHFFFAOYSA-N 0.000 description 2
- JWCOWLWBOYGUPA-UHFFFAOYSA-N 6-fluorohexan-1-ol Chemical compound OCCCCCCF JWCOWLWBOYGUPA-UHFFFAOYSA-N 0.000 description 2
- LIUSQTRCKMJXEP-UHFFFAOYSA-N 6-methyl-6-nitroheptan-2-ol Chemical compound CC(O)CCCC(C)(C)[N+]([O-])=O LIUSQTRCKMJXEP-UHFFFAOYSA-N 0.000 description 2
- SQBSQQUIASSUGB-UHFFFAOYSA-N 6-nitrohexan-1-ol Chemical compound OCCCCCC[N+]([O-])=O SQBSQQUIASSUGB-UHFFFAOYSA-N 0.000 description 2
- BZIZKLZGQRAKFR-UHFFFAOYSA-N 7-fluoroheptan-1-ol Chemical compound OCCCCCCCF BZIZKLZGQRAKFR-UHFFFAOYSA-N 0.000 description 2
- NSQGVCPOJCWINW-UHFFFAOYSA-N 7-nitroheptan-1-ol Chemical compound OCCCCCCC[N+]([O-])=O NSQGVCPOJCWINW-UHFFFAOYSA-N 0.000 description 2
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 2
- DGGXBEHZGMUMOU-UHFFFAOYSA-N 8-fluorooctan-1-ol Chemical compound OCCCCCCCCF DGGXBEHZGMUMOU-UHFFFAOYSA-N 0.000 description 2
- NVCMQUWIVFXVRL-UHFFFAOYSA-N 8-nitrooctan-1-ol Chemical compound OCCCCCCCC[N+]([O-])=O NVCMQUWIVFXVRL-UHFFFAOYSA-N 0.000 description 2
- KLHJXURNHSLXLM-UHFFFAOYSA-N 9-fluorononan-1-ol Chemical compound OCCCCCCCCCF KLHJXURNHSLXLM-UHFFFAOYSA-N 0.000 description 2
- SLLKICYJHPXTNM-UHFFFAOYSA-N 9-nitrononan-1-ol Chemical compound OCCCCCCCCC[N+]([O-])=O SLLKICYJHPXTNM-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- XYBUDGYYNGYUPX-UHFFFAOYSA-N C(=O)(OC(C)(C)C)N(C(NC(=O)O)=N)C(=O)OC(C)(C)C Chemical compound C(=O)(OC(C)(C)C)N(C(NC(=O)O)=N)C(=O)OC(C)(C)C XYBUDGYYNGYUPX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical class CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 2
- 239000004606 Fillers/Extenders Substances 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- 108010093096 Immobilized Enzymes Proteins 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- 125000003047 N-acetyl group Chemical group 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 150000001409 amidines Chemical class 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 229940125716 antipyretic agent Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- UGUUDTWORXNLAK-UHFFFAOYSA-N azidoalcohol Chemical compound ON=[N+]=[N-] UGUUDTWORXNLAK-UHFFFAOYSA-N 0.000 description 2
- 150000001541 aziridines Chemical group 0.000 description 2
- 125000004069 aziridinyl group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- LSNKBVFMXFAUOF-UHFFFAOYSA-N benzyl methanimidate;hydrochloride Chemical compound Cl.N=COCC1=CC=CC=C1 LSNKBVFMXFAUOF-UHFFFAOYSA-N 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- JRZBPELLUMBLQU-UHFFFAOYSA-N carbonazidic acid Chemical compound OC(=O)N=[N+]=[N-] JRZBPELLUMBLQU-UHFFFAOYSA-N 0.000 description 2
- 125000006244 carboxylic acid protecting group Chemical group 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 229940061627 chloromethyl methyl ether Drugs 0.000 description 2
- 238000011097 chromatography purification Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 239000012084 conversion product Substances 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- MLIREBYILWEBDM-UHFFFAOYSA-N cyanoacetic acid Chemical compound OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000010931 ester hydrolysis Methods 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- IBRZMAIAORVEIM-UHFFFAOYSA-N formylcarbamic acid Chemical compound OC(=O)NC=O IBRZMAIAORVEIM-UHFFFAOYSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 238000012750 in vivo screening Methods 0.000 description 2
- 208000037797 influenza A Diseases 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- VMVNZNXAVJHNDJ-UHFFFAOYSA-N methyl 2,2,2-trifluoroacetate Chemical compound COC(=O)C(F)(F)F VMVNZNXAVJHNDJ-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- QJQAMHYHNCADNR-UHFFFAOYSA-N n-methylpropanamide Chemical compound CCC(=O)NC QJQAMHYHNCADNR-UHFFFAOYSA-N 0.000 description 2
- 239000003883 ointment base Substances 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000003880 polar aprotic solvent Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- SUVIGLJNEAMWEG-UHFFFAOYSA-N propane-1-thiol Chemical compound CCCS SUVIGLJNEAMWEG-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- 238000000859 sublimation Methods 0.000 description 2
- 230000008022 sublimation Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- VBYPJHLRWKGNAI-UHFFFAOYSA-N tert-butyl aziridine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CC1 VBYPJHLRWKGNAI-UHFFFAOYSA-N 0.000 description 2
- QFNFDHNZVTWZED-UHFFFAOYSA-N tert-butyl n-[[(2-methylpropan-2-yl)oxycarbonylamino]-pyrazol-1-ylmethylidene]carbamate Chemical compound CC(C)(C)OC(=O)NC(=NC(=O)OC(C)(C)C)N1C=CC=N1 QFNFDHNZVTWZED-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- AYENAFNYCVQWNL-UHFFFAOYSA-N (2,2,2-trifluoroacetyl)carbamic acid Chemical compound OC(=O)NC(=O)C(F)(F)F AYENAFNYCVQWNL-UHFFFAOYSA-N 0.000 description 1
- NFAULLMVDVCOQU-SSDOTTSWSA-N (2R)-1-fluoro-2-methylhexan-2-ol Chemical compound CCCC[C@@](C)(O)CF NFAULLMVDVCOQU-SSDOTTSWSA-N 0.000 description 1
- VJCZJBJUAGHLEY-SSDOTTSWSA-N (2R)-1-nitroheptan-2-ol Chemical compound CCCCC[C@@H](O)C[N+]([O-])=O VJCZJBJUAGHLEY-SSDOTTSWSA-N 0.000 description 1
- RITXFFWHWOKLTO-RXMQYKEDSA-N (2R)-5-nitropentan-2-ol Chemical compound C[C@@H](O)CCC[N+]([O-])=O RITXFFWHWOKLTO-RXMQYKEDSA-N 0.000 description 1
- BTANRVKWQNVYAZ-SCSAIBSYSA-N (2R)-butan-2-ol Chemical compound CC[C@@H](C)O BTANRVKWQNVYAZ-SCSAIBSYSA-N 0.000 description 1
- KZTNLLVYRNPCJR-JTQLQIEISA-N (2S)-1-fluorodecan-2-ol Chemical compound CCCCCCCC[C@H](O)CF KZTNLLVYRNPCJR-JTQLQIEISA-N 0.000 description 1
- WRDZSIKOOWXDEE-VIFPVBQESA-N (2S)-1-fluorononan-2-ol Chemical compound CCCCCCC[C@H](O)CF WRDZSIKOOWXDEE-VIFPVBQESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- OKHRYHIXUNLSPK-ZETCQYMHSA-N (2S)-2-fluoro-2-methylhexan-1-ol Chemical compound CCCC[C@](C)(F)CO OKHRYHIXUNLSPK-ZETCQYMHSA-N 0.000 description 1
- BIXPLUJYBHAXHD-RXMQYKEDSA-N (2S)-2-fluoro-3,3-dimethylbutan-1-ol Chemical compound CC(C)(C)[C@H](F)CO BIXPLUJYBHAXHD-RXMQYKEDSA-N 0.000 description 1
- WYKTYEIIRULHNQ-BYPYZUCNSA-N (2S)-4-nitrobutan-2-ol Chemical compound C[C@H](O)CC[N+]([O-])=O WYKTYEIIRULHNQ-BYPYZUCNSA-N 0.000 description 1
- KZTNLLVYRNPCJR-SNVBAGLBSA-N (2r)-1-fluorodecan-2-ol Chemical compound CCCCCCCC[C@@H](O)CF KZTNLLVYRNPCJR-SNVBAGLBSA-N 0.000 description 1
- GRRGZCQZZLXSGF-YFKPBYRVSA-N (2r)-2-fluoro-3-methylbutan-1-ol Chemical compound CC(C)[C@@H](F)CO GRRGZCQZZLXSGF-YFKPBYRVSA-N 0.000 description 1
- ZFNTVJZUVCUSNP-ZCFIWIBFSA-N (2r)-2-fluoro-4-methylpentan-1-ol Chemical compound CC(C)C[C@@H](F)CO ZFNTVJZUVCUSNP-ZCFIWIBFSA-N 0.000 description 1
- LRKCNYYCJZXSHR-SECBINFHSA-N (2r)-2-fluorononan-1-ol Chemical compound CCCCCCC[C@@H](F)CO LRKCNYYCJZXSHR-SECBINFHSA-N 0.000 description 1
- PXUHUAWWMDRECM-MRVPVSSYSA-N (2r)-2-fluorooctan-1-ol Chemical compound CCCCCC[C@@H](F)CO PXUHUAWWMDRECM-MRVPVSSYSA-N 0.000 description 1
- WYKTYEIIRULHNQ-SCSAIBSYSA-N (2r)-4-nitrobutan-2-ol Chemical compound C[C@@H](O)CC[N+]([O-])=O WYKTYEIIRULHNQ-SCSAIBSYSA-N 0.000 description 1
- KLGNQHRPPLDIFC-QMMMGPOBSA-N (2s)-1-fluorooctan-2-ol Chemical compound CCCCCC[C@H](O)CF KLGNQHRPPLDIFC-QMMMGPOBSA-N 0.000 description 1
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 1
- GRRGZCQZZLXSGF-RXMQYKEDSA-N (2s)-2-fluoro-3-methylbutan-1-ol Chemical compound CC(C)[C@H](F)CO GRRGZCQZZLXSGF-RXMQYKEDSA-N 0.000 description 1
- SJZQQJOIMGMRKP-JTQLQIEISA-N (2s)-2-fluorodecan-1-ol Chemical compound CCCCCCCC[C@H](F)CO SJZQQJOIMGMRKP-JTQLQIEISA-N 0.000 description 1
- PYMZAXRFSIFPKK-LBPRGKRZSA-N (2s)-2-fluorododecan-1-ol Chemical compound CCCCCCCCCC[C@H](F)CO PYMZAXRFSIFPKK-LBPRGKRZSA-N 0.000 description 1
- UEBHTEIKXIPNGN-ZETCQYMHSA-N (2s)-2-fluoroheptan-1-ol Chemical compound CCCCC[C@H](F)CO UEBHTEIKXIPNGN-ZETCQYMHSA-N 0.000 description 1
- NVIVQGNQOLBSLT-LURJTMIESA-N (2s)-2-fluorohexan-1-ol Chemical compound CCCC[C@H](F)CO NVIVQGNQOLBSLT-LURJTMIESA-N 0.000 description 1
- LRKCNYYCJZXSHR-VIFPVBQESA-N (2s)-2-fluorononan-1-ol Chemical compound CCCCCCC[C@H](F)CO LRKCNYYCJZXSHR-VIFPVBQESA-N 0.000 description 1
- PXUHUAWWMDRECM-QMMMGPOBSA-N (2s)-2-fluorooctan-1-ol Chemical compound CCCCCC[C@H](F)CO PXUHUAWWMDRECM-QMMMGPOBSA-N 0.000 description 1
- MVFMATZFWFEEKJ-BYPYZUCNSA-N (2s)-3-methyl-3-nitrobutan-2-ol Chemical compound C[C@H](O)C(C)(C)[N+]([O-])=O MVFMATZFWFEEKJ-BYPYZUCNSA-N 0.000 description 1
- RITXFFWHWOKLTO-YFKPBYRVSA-N (2s)-5-nitropentan-2-ol Chemical compound C[C@H](O)CCC[N+]([O-])=O RITXFFWHWOKLTO-YFKPBYRVSA-N 0.000 description 1
- 239000001618 (3R)-3-methylpentan-1-ol Substances 0.000 description 1
- DQYNJGWRTSPODI-ZCFIWIBFSA-N (3R)-6-nitrohexan-3-ol Chemical compound CC[C@@H](O)CCC[N+]([O-])=O DQYNJGWRTSPODI-ZCFIWIBFSA-N 0.000 description 1
- BKRMAGHMLGFMJT-YFKPBYRVSA-N (3S)-1-nitropentan-3-ol Chemical compound CC[C@H](O)CC[N+]([O-])=O BKRMAGHMLGFMJT-YFKPBYRVSA-N 0.000 description 1
- FNHHVPPSBFQMEL-KQHDFZBMSA-N (3S)-5-N-[(1S,5R)-3-hydroxy-6-bicyclo[3.1.0]hexanyl]-7-N,3-dimethyl-3-phenyl-2H-1-benzofuran-5,7-dicarboxamide Chemical compound CNC(=O)c1cc(cc2c1OC[C@@]2(C)c1ccccc1)C(=O)NC1[C@H]2CC(O)C[C@@H]12 FNHHVPPSBFQMEL-KQHDFZBMSA-N 0.000 description 1
- BKRMAGHMLGFMJT-RXMQYKEDSA-N (3r)-1-nitropentan-3-ol Chemical compound CC[C@@H](O)CC[N+]([O-])=O BKRMAGHMLGFMJT-RXMQYKEDSA-N 0.000 description 1
- NOUZIWJKLXBBOH-SSDOTTSWSA-N (3r)-3-fluoroheptan-1-ol Chemical compound CCCC[C@@H](F)CCO NOUZIWJKLXBBOH-SSDOTTSWSA-N 0.000 description 1
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 description 1
- NOUZIWJKLXBBOH-ZETCQYMHSA-N (3s)-3-fluoroheptan-1-ol Chemical compound CCCC[C@H](F)CCO NOUZIWJKLXBBOH-ZETCQYMHSA-N 0.000 description 1
- QVKRBXFLYCUYMP-VIFPVBQESA-N (3s)-3-fluorononan-1-ol Chemical compound CCCCCC[C@H](F)CCO QVKRBXFLYCUYMP-VIFPVBQESA-N 0.000 description 1
- DQYNJGWRTSPODI-LURJTMIESA-N (3s)-6-nitrohexan-3-ol Chemical compound CC[C@H](O)CCC[N+]([O-])=O DQYNJGWRTSPODI-LURJTMIESA-N 0.000 description 1
- STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 description 1
- DRJIHNSDCCEQLL-QMMMGPOBSA-N (4s)-1-nitrooctan-4-ol Chemical compound CCCC[C@H](O)CCC[N+]([O-])=O DRJIHNSDCCEQLL-QMMMGPOBSA-N 0.000 description 1
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 description 1
- XPIJMQVLTXAGME-UHFFFAOYSA-N 1,1-dimethoxycyclohexane Chemical compound COC1(OC)CCCCC1 XPIJMQVLTXAGME-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 150000000180 1,2-diols Chemical group 0.000 description 1
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 1
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 1
- UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 description 1
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N 1-butanol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- GJUCEPWSOMEEKT-UHFFFAOYSA-N 1-fluoro-2,3-dimethylbutan-2-ol Chemical compound CC(C)C(C)(O)CF GJUCEPWSOMEEKT-UHFFFAOYSA-N 0.000 description 1
- KZTNLLVYRNPCJR-UHFFFAOYSA-N 1-fluorodecan-2-ol Chemical compound CCCCCCCCC(O)CF KZTNLLVYRNPCJR-UHFFFAOYSA-N 0.000 description 1
- ANCGAPPEFCPNMP-UHFFFAOYSA-N 1-fluorodecan-5-ol Chemical compound CCCCCC(O)CCCCF ANCGAPPEFCPNMP-UHFFFAOYSA-N 0.000 description 1
- QZGYKAWLZIQCPN-UHFFFAOYSA-N 1-fluorododecan-1-ol Chemical compound CCCCCCCCCCCC(O)F QZGYKAWLZIQCPN-UHFFFAOYSA-N 0.000 description 1
- SIXHNKZQLHNSGP-UHFFFAOYSA-N 1-fluorododecan-2-ol Chemical compound CCCCCCCCCCC(O)CF SIXHNKZQLHNSGP-UHFFFAOYSA-N 0.000 description 1
- RZYULFKPZNCXTB-UHFFFAOYSA-N 1-fluoroheptan-3-ol Chemical compound CCCCC(O)CCF RZYULFKPZNCXTB-UHFFFAOYSA-N 0.000 description 1
- LVOQCSLRNKCYLQ-UHFFFAOYSA-N 1-fluorohexan-3-ol Chemical compound CCCC(O)CCF LVOQCSLRNKCYLQ-UHFFFAOYSA-N 0.000 description 1
- YVRDLTGHVVBLDA-UHFFFAOYSA-N 1-fluorononan-3-ol Chemical compound CCCCCCC(O)CCF YVRDLTGHVVBLDA-UHFFFAOYSA-N 0.000 description 1
- JUXYSVUBIQJRGS-UHFFFAOYSA-N 1-fluoropentan-3-ol Chemical compound CCC(O)CCF JUXYSVUBIQJRGS-UHFFFAOYSA-N 0.000 description 1
- NLKHGXNCSZJXRE-UHFFFAOYSA-N 1-nitrodecan-2-ol Chemical compound CCCCCCCCC(O)C[N+]([O-])=O NLKHGXNCSZJXRE-UHFFFAOYSA-N 0.000 description 1
- HFFFAFPPYWBBIR-UHFFFAOYSA-N 1-nitroheptan-4-ol Chemical compound CCCC(O)CCC[N+]([O-])=O HFFFAFPPYWBBIR-UHFFFAOYSA-N 0.000 description 1
- MGGGUUMQEMJSNJ-UHFFFAOYSA-N 1-nitrohexan-2-ol Chemical compound CCCCC(O)C[N+]([O-])=O MGGGUUMQEMJSNJ-UHFFFAOYSA-N 0.000 description 1
- VQBXYLSXCORZGJ-UHFFFAOYSA-N 1-nitrononan-2-ol Chemical compound CCCCCCCC(O)C[N+]([O-])=O VQBXYLSXCORZGJ-UHFFFAOYSA-N 0.000 description 1
- DRJIHNSDCCEQLL-UHFFFAOYSA-N 1-nitrooctan-4-ol Chemical compound CCCCC(O)CCC[N+]([O-])=O DRJIHNSDCCEQLL-UHFFFAOYSA-N 0.000 description 1
- BKRMAGHMLGFMJT-UHFFFAOYSA-N 1-nitropentan-3-ol Chemical compound CCC(O)CC[N+]([O-])=O BKRMAGHMLGFMJT-UHFFFAOYSA-N 0.000 description 1
- OLZUCPDJVBXMFC-UHFFFAOYSA-N 10-fluoro-2-methyldecan-1-ol Chemical compound OCC(C)CCCCCCCCF OLZUCPDJVBXMFC-UHFFFAOYSA-N 0.000 description 1
- ALUAXHOULLAYIV-UHFFFAOYSA-N 11-fluoro-2-methylundecan-2-ol Chemical compound CC(C)(O)CCCCCCCCCF ALUAXHOULLAYIV-UHFFFAOYSA-N 0.000 description 1
- MKJMKQDVRQGWIN-UHFFFAOYSA-N 11-nitroundecan-5-ol Chemical compound CCCCC(O)CCCCCC[N+]([O-])=O MKJMKQDVRQGWIN-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- DOBXRIIYJDDGMW-UHFFFAOYSA-N 2,2,4,4-tetramethyl-3-(nitromethyl)pentan-3-ol Chemical compound CC(C)(C)C(O)(C(C)(C)C)C[N+]([O-])=O DOBXRIIYJDDGMW-UHFFFAOYSA-N 0.000 description 1
- FENXWSIHLBOCOU-UHFFFAOYSA-N 2,2-dimethyl-4-nitrononan-3-ol Chemical compound CCCCCC([N+]([O-])=O)C(O)C(C)(C)C FENXWSIHLBOCOU-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- HKZHQZUAKVJYIZ-UHFFFAOYSA-N 2,3-dimethyl-1-nitrobutan-2-ol Chemical compound CC(C)C(C)(O)C[N+]([O-])=O HKZHQZUAKVJYIZ-UHFFFAOYSA-N 0.000 description 1
- KMUWIXHDMPMULL-UHFFFAOYSA-N 2,3-dimethyl-3-nitrobutan-1-ol Chemical compound OCC(C)C(C)(C)[N+]([O-])=O KMUWIXHDMPMULL-UHFFFAOYSA-N 0.000 description 1
- QAOAMCQLMQIMMW-UHFFFAOYSA-N 2,3-dimethyl-3-nitrobutan-2-ol Chemical compound CC(C)(O)C(C)(C)[N+]([O-])=O QAOAMCQLMQIMMW-UHFFFAOYSA-N 0.000 description 1
- MPERRNLTDKMQTN-UHFFFAOYSA-N 2,4,4-trimethyl-1-nitropentan-2-ol Chemical compound CC(C)(C)CC(C)(O)C[N+]([O-])=O MPERRNLTDKMQTN-UHFFFAOYSA-N 0.000 description 1
- FKOHSZUQSFEPKG-UHFFFAOYSA-N 2,5-dimethyl-1-nitrohexan-3-ol Chemical compound CC(C)CC(O)C(C)C[N+]([O-])=O FKOHSZUQSFEPKG-UHFFFAOYSA-N 0.000 description 1
- UHUKFMFXIIXGMX-UHFFFAOYSA-N 2,5-dimethyl-4-nitrohexan-3-ol Chemical compound CC(C)C(O)C(C(C)C)[N+]([O-])=O UHUKFMFXIIXGMX-UHFFFAOYSA-N 0.000 description 1
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 1
- WUUKSIZJXIORDG-UHFFFAOYSA-N 2,6-dimethyl-6-nitroheptan-2-ol Chemical compound CC(C)(O)CCCC(C)(C)[N+]([O-])=O WUUKSIZJXIORDG-UHFFFAOYSA-N 0.000 description 1
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- XJDGGHYRNCSSGD-UHFFFAOYSA-N 2-(fluoromethyl)-2-methylpentan-1-ol Chemical compound CCCC(C)(CO)CF XJDGGHYRNCSSGD-UHFFFAOYSA-N 0.000 description 1
- VRPJIFMKZZEXLR-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid Chemical compound CC(C)(C)OC(=O)NCC(O)=O VRPJIFMKZZEXLR-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 1
- XZUFESJDDBOWHJ-UHFFFAOYSA-N 2-ethyl-2-(fluoromethyl)butan-1-ol Chemical compound CCC(CC)(CO)CF XZUFESJDDBOWHJ-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- FNSDYJBAZKKTPR-UHFFFAOYSA-N 2-fluoro-2,3-dimethylbutan-1-ol Chemical compound CC(C)C(C)(F)CO FNSDYJBAZKKTPR-UHFFFAOYSA-N 0.000 description 1
- BFIUZJIVOBAMGC-UHFFFAOYSA-N 2-fluoro-2,5-dimethylnonan-5-ol Chemical compound CCCCC(C)(O)CCC(C)(C)F BFIUZJIVOBAMGC-UHFFFAOYSA-N 0.000 description 1
- YTZUHOYRFWCYAX-UHFFFAOYSA-N 2-fluoro-2,6-dimethylheptan-3-ol Chemical compound CC(C)CCC(O)C(C)(C)F YTZUHOYRFWCYAX-UHFFFAOYSA-N 0.000 description 1
- JTADSDIQROXXJS-UHFFFAOYSA-N 2-fluoro-2-methylbutan-1-ol Chemical compound CCC(C)(F)CO JTADSDIQROXXJS-UHFFFAOYSA-N 0.000 description 1
- UAUZAIOTENQPSA-UHFFFAOYSA-N 2-fluoro-2-methylheptan-1-ol Chemical compound CCCCCC(C)(F)CO UAUZAIOTENQPSA-UHFFFAOYSA-N 0.000 description 1
- KFGKCNVTICEZTA-UHFFFAOYSA-N 2-fluoro-2-methyloctan-1-ol Chemical compound CCCCCCC(C)(F)CO KFGKCNVTICEZTA-UHFFFAOYSA-N 0.000 description 1
- UCLKDKHIDQBUJE-UHFFFAOYSA-N 2-fluoro-2-methylpentan-1-ol Chemical compound CCCC(C)(F)CO UCLKDKHIDQBUJE-UHFFFAOYSA-N 0.000 description 1
- DAHFDQKKODDTCB-UHFFFAOYSA-N 2-fluoro-4-methylheptan-3-ol Chemical compound CCCC(C)C(O)C(C)F DAHFDQKKODDTCB-UHFFFAOYSA-N 0.000 description 1
- ZFNTVJZUVCUSNP-UHFFFAOYSA-N 2-fluoro-4-methylpentan-1-ol Chemical compound CC(C)CC(F)CO ZFNTVJZUVCUSNP-UHFFFAOYSA-N 0.000 description 1
- IZMAVOMSWXQOEU-UHFFFAOYSA-N 2-fluoro-5-methylhexan-1-ol Chemical compound CC(C)CCC(F)CO IZMAVOMSWXQOEU-UHFFFAOYSA-N 0.000 description 1
- MXROEWVKLWYHJD-UHFFFAOYSA-N 2-fluoro-6-methylheptan-1-ol Chemical compound CC(C)CCCC(F)CO MXROEWVKLWYHJD-UHFFFAOYSA-N 0.000 description 1
- UEBHTEIKXIPNGN-UHFFFAOYSA-N 2-fluoroheptan-1-ol Chemical compound CCCCCC(F)CO UEBHTEIKXIPNGN-UHFFFAOYSA-N 0.000 description 1
- NVIVQGNQOLBSLT-UHFFFAOYSA-N 2-fluorohexan-1-ol Chemical compound CCCCC(F)CO NVIVQGNQOLBSLT-UHFFFAOYSA-N 0.000 description 1
- LRKCNYYCJZXSHR-UHFFFAOYSA-N 2-fluorononan-1-ol Chemical compound CCCCCCCC(F)CO LRKCNYYCJZXSHR-UHFFFAOYSA-N 0.000 description 1
- OMAFODCGMXDASL-UHFFFAOYSA-N 2-fluoropentan-1-ol Chemical compound CCCC(F)CO OMAFODCGMXDASL-UHFFFAOYSA-N 0.000 description 1
- GAKWSSRONDZJSX-UHFFFAOYSA-N 2-fluoroundecan-1-ol Chemical compound CCCCCCCCCC(F)CO GAKWSSRONDZJSX-UHFFFAOYSA-N 0.000 description 1
- QRZCBWQBMNDFGW-UHFFFAOYSA-N 2-methyl-1-nitrohexan-3-ol Chemical compound CCCC(O)C(C)C[N+]([O-])=O QRZCBWQBMNDFGW-UHFFFAOYSA-N 0.000 description 1
- GOEAVKJNNDQUAO-UHFFFAOYSA-N 2-methyl-1-nitrooctan-3-ol Chemical compound CCCCCC(O)C(C)C[N+]([O-])=O GOEAVKJNNDQUAO-UHFFFAOYSA-N 0.000 description 1
- QDGGABYPSJOCQS-UHFFFAOYSA-N 2-methyl-1-nitropentan-2-ol Chemical compound CCCC(C)(O)C[N+]([O-])=O QDGGABYPSJOCQS-UHFFFAOYSA-N 0.000 description 1
- PFNHSEQQEPMLNI-UHFFFAOYSA-N 2-methyl-1-pentanol Substances CCCC(C)CO PFNHSEQQEPMLNI-UHFFFAOYSA-N 0.000 description 1
- MHHBWCNPCLJUQT-UHFFFAOYSA-N 2-methyl-2-nitrononan-3-ol Chemical compound CCCCCCC(O)C(C)(C)[N+]([O-])=O MHHBWCNPCLJUQT-UHFFFAOYSA-N 0.000 description 1
- HPHJFUPTSXGPJM-UHFFFAOYSA-N 2-methyl-2-nitroundecan-3-ol Chemical compound CCCCCCCCC(O)C(C)(C)[N+]([O-])=O HPHJFUPTSXGPJM-UHFFFAOYSA-N 0.000 description 1
- MGQQOLSAJAOAJS-UHFFFAOYSA-N 2-methyl-3-(nitromethyl)hept-3-en-1-ol Chemical compound CCCC=C(C[N+]([O-])=O)C(C)CO MGQQOLSAJAOAJS-UHFFFAOYSA-N 0.000 description 1
- NRAHZWWOUFWJGR-UHFFFAOYSA-N 2-methyl-3-nitrobutan-1-ol Chemical compound OCC(C)C(C)[N+]([O-])=O NRAHZWWOUFWJGR-UHFFFAOYSA-N 0.000 description 1
- XOOAQXITNKYJCD-UHFFFAOYSA-N 2-methyl-3-nitrobutan-2-ol Chemical compound [O-][N+](=O)C(C)C(C)(C)O XOOAQXITNKYJCD-UHFFFAOYSA-N 0.000 description 1
- FBVKJVNVZHVMGW-UHFFFAOYSA-N 2-methyl-3-nitropentan-1-ol Chemical compound CCC([N+]([O-])=O)C(C)CO FBVKJVNVZHVMGW-UHFFFAOYSA-N 0.000 description 1
- LJILCIAFGJYJDK-UHFFFAOYSA-N 2-methyl-3-nitropropan-1-ol Chemical compound OCC(C)C[N+]([O-])=O LJILCIAFGJYJDK-UHFFFAOYSA-N 0.000 description 1
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
- FSJZGJIIPILZQK-UHFFFAOYSA-N 2-nitrodecan-4-ol Chemical compound CCCCCCC(O)CC(C)[N+]([O-])=O FSJZGJIIPILZQK-UHFFFAOYSA-N 0.000 description 1
- JMWUXGYZNJBRMA-UHFFFAOYSA-N 2-nitrododecan-3-ol Chemical compound CCCCCCCCCC(O)C(C)[N+]([O-])=O JMWUXGYZNJBRMA-UHFFFAOYSA-N 0.000 description 1
- SLKZLAMPKCXMAI-UHFFFAOYSA-N 2-nitrononan-3-ol Chemical compound CCCCCCC(O)C(C)[N+]([O-])=O SLKZLAMPKCXMAI-UHFFFAOYSA-N 0.000 description 1
- PJZKSNPFLKEFHX-UHFFFAOYSA-N 2-nitrooctan-3-ol Chemical compound CCCCCC(O)C(C)[N+]([O-])=O PJZKSNPFLKEFHX-UHFFFAOYSA-N 0.000 description 1
- NCQZFTUKRHTFMX-UHFFFAOYSA-N 2-nitroundecan-3-ol Chemical compound CCCCCCCCC(O)C(C)[N+]([O-])=O NCQZFTUKRHTFMX-UHFFFAOYSA-N 0.000 description 1
- JYVLIDXNZAXMDK-UHFFFAOYSA-N 2-pentanol Substances CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 description 1
- CKRVOEVAAZDRMM-UHFFFAOYSA-N 3,3-dimethyl-2-nitrobutan-1-ol Chemical compound CC(C)(C)C(CO)[N+]([O-])=O CKRVOEVAAZDRMM-UHFFFAOYSA-N 0.000 description 1
- ZOHMNVPRSUYGIP-UHFFFAOYSA-N 3,4-dimethyl-1-nitrohexan-2-ol Chemical compound CCC(C)C(C)C(O)C[N+]([O-])=O ZOHMNVPRSUYGIP-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- SVDVGLLYKJZIIZ-UHFFFAOYSA-N 3-(nitromethyl)heptan-4-ol Chemical compound CCCC(O)C(CC)C[N+]([O-])=O SVDVGLLYKJZIIZ-UHFFFAOYSA-N 0.000 description 1
- YLBJVOGWRMXWET-UHFFFAOYSA-N 3-(nitromethyl)pentan-3-ol Chemical compound CCC(O)(CC)C[N+]([O-])=O YLBJVOGWRMXWET-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- QQALKLGNPUDVQC-UHFFFAOYSA-N 3-ethyl-2-nitropentan-3-ol Chemical compound CCC(O)(CC)C(C)[N+]([O-])=O QQALKLGNPUDVQC-UHFFFAOYSA-N 0.000 description 1
- FHQGTWJIAUOEEJ-UHFFFAOYSA-N 3-ethyl-4-nitropentan-1-ol Chemical compound OCCC(CC)C(C)[N+]([O-])=O FHQGTWJIAUOEEJ-UHFFFAOYSA-N 0.000 description 1
- KVBBMCNRIZHRMS-UHFFFAOYSA-N 3-fluoro-2-methylbutan-2-ol Chemical compound CC(F)C(C)(C)O KVBBMCNRIZHRMS-UHFFFAOYSA-N 0.000 description 1
- FHKUEBFUICVIIB-UHFFFAOYSA-N 3-fluoro-2-methylpentan-2-ol Chemical compound CCC(F)C(C)(C)O FHKUEBFUICVIIB-UHFFFAOYSA-N 0.000 description 1
- ZLKPVVZVRZPBQM-UHFFFAOYSA-N 3-fluoro-3-methylbutan-2-ol Chemical compound CC(O)C(C)(C)F ZLKPVVZVRZPBQM-UHFFFAOYSA-N 0.000 description 1
- DUVVLMMTTVKUEZ-UHFFFAOYSA-N 3-fluoro-3-methylpentan-1-ol Chemical compound CCC(C)(F)CCO DUVVLMMTTVKUEZ-UHFFFAOYSA-N 0.000 description 1
- KUOMEPXVIPTJJX-UHFFFAOYSA-N 3-fluorobutan-2-ol Chemical compound CC(O)C(C)F KUOMEPXVIPTJJX-UHFFFAOYSA-N 0.000 description 1
- QVKRBXFLYCUYMP-UHFFFAOYSA-N 3-fluorononan-1-ol Chemical compound CCCCCCC(F)CCO QVKRBXFLYCUYMP-UHFFFAOYSA-N 0.000 description 1
- IRHFXWUELYRLLX-UHFFFAOYSA-N 3-fluorononan-2-ol Chemical compound CCCCCCC(F)C(C)O IRHFXWUELYRLLX-UHFFFAOYSA-N 0.000 description 1
- ZSJGEQLPOOUWPQ-UHFFFAOYSA-N 3-methyl-1-nitrobutan-1-ol Chemical compound CC(C)CC(O)[N+]([O-])=O ZSJGEQLPOOUWPQ-UHFFFAOYSA-N 0.000 description 1
- BZWWMLNELIGOOV-UHFFFAOYSA-N 3-methyl-3-nitrobutan-1-ol Chemical compound [O-][N+](=O)C(C)(C)CCO BZWWMLNELIGOOV-UHFFFAOYSA-N 0.000 description 1
- IZZUIVNQRYQJNU-UHFFFAOYSA-N 3-methyl-4-nitrobutan-1-ol Chemical compound OCCC(C)C[N+]([O-])=O IZZUIVNQRYQJNU-UHFFFAOYSA-N 0.000 description 1
- RKQUFYHTDOJIOK-UHFFFAOYSA-N 3-methyl-4-nitrobutan-2-ol Chemical compound CC(O)C(C)C[N+]([O-])=O RKQUFYHTDOJIOK-UHFFFAOYSA-N 0.000 description 1
- OYNIAQUIUPRRFP-UHFFFAOYSA-N 3-nitrodecan-4-ol Chemical compound CCCCCCC(O)C(CC)[N+]([O-])=O OYNIAQUIUPRRFP-UHFFFAOYSA-N 0.000 description 1
- ZCXNKFOBXWHRSV-UHFFFAOYSA-N 3-nitrohexan-2-ol Chemical compound CCCC(C(C)O)[N+]([O-])=O ZCXNKFOBXWHRSV-UHFFFAOYSA-N 0.000 description 1
- WLTRWPLDNBAPGP-UHFFFAOYSA-N 3-nitrooctan-2-ol Chemical compound CCCCCC(C(C)O)[N+]([O-])=O WLTRWPLDNBAPGP-UHFFFAOYSA-N 0.000 description 1
- ZRFMODAXLAHRLV-UHFFFAOYSA-N 3-nitropentan-1-ol Chemical compound CCC([N+]([O-])=O)CCO ZRFMODAXLAHRLV-UHFFFAOYSA-N 0.000 description 1
- BZKMQYVECSXZCK-UHFFFAOYSA-N 4,6,6-trimethyl-1-nitroheptan-2-ol Chemical compound CC(C)(C)CC(C)CC(O)C[N+]([O-])=O BZKMQYVECSXZCK-UHFFFAOYSA-N 0.000 description 1
- AJBAYRRIDKXWOE-UHFFFAOYSA-N 4,8-dimethyl-2-nitrononan-1-ol Chemical compound CC(C)CCCC(C)CC(CO)[N+]([O-])=O AJBAYRRIDKXWOE-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- CBPLISSMCMFSIN-UHFFFAOYSA-N 4-ethyl-2-nitrohexan-3-ol Chemical compound CCC(CC)C(O)C(C)[N+]([O-])=O CBPLISSMCMFSIN-UHFFFAOYSA-N 0.000 description 1
- DQAZPZIYEOGZAF-UHFFFAOYSA-N 4-ethyl-n-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide Chemical compound C1CN(CC)CCN1C(=O)NC(C(=CC1=NC=N2)OC)=CC1=C2NC1=CC=CC(C#C)=C1 DQAZPZIYEOGZAF-UHFFFAOYSA-N 0.000 description 1
- XRPIJKJYQDENFB-UHFFFAOYSA-N 4-fluoro-2,2,5,5-tetramethylhexan-3-ol Chemical compound CC(C)(C)C(O)C(F)C(C)(C)C XRPIJKJYQDENFB-UHFFFAOYSA-N 0.000 description 1
- QCLXLDNWWLHSGT-UHFFFAOYSA-N 4-fluoro-3-methylbutan-1-ol Chemical compound FCC(C)CCO QCLXLDNWWLHSGT-UHFFFAOYSA-N 0.000 description 1
- UYJNFDNVJFXENL-UHFFFAOYSA-N 4-fluoro-3-methylpentan-2-ol Chemical compound CC(O)C(C)C(C)F UYJNFDNVJFXENL-UHFFFAOYSA-N 0.000 description 1
- ODBRPUWGTQGUJC-UHFFFAOYSA-N 4-fluorodecan-1-ol Chemical compound CCCCCCC(F)CCCO ODBRPUWGTQGUJC-UHFFFAOYSA-N 0.000 description 1
- JBALFAVSZHYFAI-UHFFFAOYSA-N 4-fluoropentan-2-ol Chemical compound CC(O)CC(C)F JBALFAVSZHYFAI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- VTVYCMWKOCOBQA-UHFFFAOYSA-N 4-nitrononan-3-ol Chemical compound CCCCCC([N+]([O-])=O)C(O)CC VTVYCMWKOCOBQA-UHFFFAOYSA-N 0.000 description 1
- FLBFJHMJCNKWRH-UHFFFAOYSA-N 4-nitrononan-5-ol Chemical compound CCCCC(O)C([N+]([O-])=O)CCC FLBFJHMJCNKWRH-UHFFFAOYSA-N 0.000 description 1
- JRNRLGRUKBLBRK-UHFFFAOYSA-N 4-nitropentan-1-ol Chemical compound [O-][N+](=O)C(C)CCCO JRNRLGRUKBLBRK-UHFFFAOYSA-N 0.000 description 1
- ORKHXTYMCYARRA-UHFFFAOYSA-N 5,5-dimethyl-4-(2-nitroethyl)hexan-1-ol Chemical compound OCCCC(C(C)(C)C)CC[N+]([O-])=O ORKHXTYMCYARRA-UHFFFAOYSA-N 0.000 description 1
- XLHBOQBARWJRAK-UHFFFAOYSA-N 5-fluoro-5-methylhexan-1-ol Chemical compound CC(C)(F)CCCCO XLHBOQBARWJRAK-UHFFFAOYSA-N 0.000 description 1
- XJPCCWCEAMDGKM-UHFFFAOYSA-N 5-fluorohexan-3-ol Chemical compound CCC(O)CC(C)F XJPCCWCEAMDGKM-UHFFFAOYSA-N 0.000 description 1
- MKVRLWWQPSVRBJ-UHFFFAOYSA-N 5-nitrodecan-2-ol Chemical compound CCCCCC([N+]([O-])=O)CCC(C)O MKVRLWWQPSVRBJ-UHFFFAOYSA-N 0.000 description 1
- OQOFJKJLWUZWHF-UHFFFAOYSA-N 5-nitrohexan-2-ol Chemical compound CC(O)CCC(C)[N+]([O-])=O OQOFJKJLWUZWHF-UHFFFAOYSA-N 0.000 description 1
- RITXFFWHWOKLTO-UHFFFAOYSA-N 5-nitropentan-2-ol Chemical compound CC(O)CCC[N+]([O-])=O RITXFFWHWOKLTO-UHFFFAOYSA-N 0.000 description 1
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 1
- XBBXATPGTYBKKS-UHFFFAOYSA-N 6-fluoro-2,6-dimethylheptan-2-ol Chemical compound CC(C)(O)CCCC(C)(C)F XBBXATPGTYBKKS-UHFFFAOYSA-N 0.000 description 1
- CSALSJNVKGHHCO-UHFFFAOYSA-N 6-fluoro-6-methylheptan-1-ol Chemical compound CC(C)(F)CCCCCO CSALSJNVKGHHCO-UHFFFAOYSA-N 0.000 description 1
- VTARPGIHWUMQPN-UHFFFAOYSA-N 6-nitrohexan-2-ol Chemical compound CC(O)CCCC[N+]([O-])=O VTARPGIHWUMQPN-UHFFFAOYSA-N 0.000 description 1
- DQYNJGWRTSPODI-UHFFFAOYSA-N 6-nitrohexan-3-ol Chemical compound CCC(O)CCC[N+]([O-])=O DQYNJGWRTSPODI-UHFFFAOYSA-N 0.000 description 1
- SMEXYHATZFOJJB-UHFFFAOYSA-N 7-fluoroheptan-2-ol Chemical compound CC(O)CCCCCF SMEXYHATZFOJJB-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000711404 Avian avulavirus 1 Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 238000006222 Berchtold homologation reaction Methods 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 239000004358 Butane-1, 3-diol Substances 0.000 description 1
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 description 1
- HDKVSEUEUWKMFS-UHFFFAOYSA-N CCOC(C1=CCCCC1)=O Chemical compound CCOC(C1=CCCCC1)=O HDKVSEUEUWKMFS-UHFFFAOYSA-N 0.000 description 1
- GIZMZDIWIKHHBC-SFYZADRCSA-N CCOC(C1=CC[C@H]2O[C@H]2C1)=O Chemical compound CCOC(C1=CC[C@H]2O[C@H]2C1)=O GIZMZDIWIKHHBC-SFYZADRCSA-N 0.000 description 1
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000712469 Fowl plague virus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 241000711408 Murine respirovirus Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000872931 Myoporum sandwicense Species 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 1
- RPUGMEHVUNTNCN-UHFFFAOYSA-N NN=CS(=O)(=O)O.C(=O)(OC(C)(C)C)NC(NC(=O)OC(C)(C)C)=S Chemical compound NN=CS(=O)(=O)O.C(=O)(OC(C)(C)C)NC(NC(=O)OC(C)(C)C)=S RPUGMEHVUNTNCN-UHFFFAOYSA-N 0.000 description 1
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 102000015731 Peptide Hormones Human genes 0.000 description 1
- 108010038988 Peptide Hormones Proteins 0.000 description 1
- 241000283216 Phocidae Species 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102100028755 Sialidase-2 Human genes 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108010034949 Thyroglobulin Proteins 0.000 description 1
- 102000009843 Thyroglobulin Human genes 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- ITLHXEGAYQFOHJ-UHFFFAOYSA-N [diazo(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(=[N+]=[N-])C1=CC=CC=C1 ITLHXEGAYQFOHJ-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 231100000230 acceptable toxicity Toxicity 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- HFEHLDPGIKPNKL-UHFFFAOYSA-N allyl iodide Chemical compound ICC=C HFEHLDPGIKPNKL-UHFFFAOYSA-N 0.000 description 1
- 125000000746 allylic group Chemical group 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- 238000010640 amide synthesis reaction Methods 0.000 description 1
- 125000005219 aminonitrile group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 150000001450 anions Chemical group 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010549 co-Evaporation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940126179 compound 72 Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 231100000223 dermal penetration Toxicity 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- UZUODNWWWUQRIR-UHFFFAOYSA-L disodium;3-aminonaphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].C1=CC=C(S([O-])(=O)=O)C2=CC(N)=CC(S([O-])(=O)=O)=C21 UZUODNWWWUQRIR-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000008387 emulsifying waxe Substances 0.000 description 1
- JPGQOUSTVILISH-UHFFFAOYSA-N enflurane Chemical compound FC(F)OC(F)(F)C(F)Cl JPGQOUSTVILISH-UHFFFAOYSA-N 0.000 description 1
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- DZFYOYRNBGNPJW-UHFFFAOYSA-N ethoxythallium Chemical compound [Tl+].CC[O-] DZFYOYRNBGNPJW-UHFFFAOYSA-N 0.000 description 1
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000012500 ion exchange media Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000006101 laboratory sample Substances 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000003819 low-pressure liquid chromatography Methods 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 238000003328 mesylation reaction Methods 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000007932 molded tablet Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 229940066491 mucolytics Drugs 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- LHEGUAPKCRQFSV-UHFFFAOYSA-N n,3-dihydroxy-3-methylbutan-2-imine oxide Chemical compound O[N+]([O-])=C(C)C(C)(C)O LHEGUAPKCRQFSV-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 238000003408 phase transfer catalysis Methods 0.000 description 1
- WJCXADMLESSGRI-UHFFFAOYSA-N phenyl selenohypochlorite Chemical compound Cl[Se]C1=CC=CC=C1 WJCXADMLESSGRI-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- UCQFSGCWHRTMGG-UHFFFAOYSA-N pyrazole-1-carboximidamide Chemical class NC(=N)N1C=CC=N1 UCQFSGCWHRTMGG-UHFFFAOYSA-N 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- 229960000888 rimantadine Drugs 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 125000005629 sialic acid group Chemical group 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- SBCLSTWHYCWVLP-UHFFFAOYSA-N tert-butyl n-methyl-n-[(2-methylpropan-2-yl)oxycarbonylcarbamothioyl]carbamate Chemical compound CC(C)(C)OC(=O)N(C)C(S)=NC(=O)OC(C)(C)C SBCLSTWHYCWVLP-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229960002175 thyroglobulin Drugs 0.000 description 1
- 229940100611 topical cream Drugs 0.000 description 1
- 229940100615 topical ointment Drugs 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 1
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 1
- OHSJPLSEQNCRLW-UHFFFAOYSA-N triphenylmethyl radical Chemical compound C1=CC=CC=C1[C](C=1C=CC=CC=1)C1=CC=CC=C1 OHSJPLSEQNCRLW-UHFFFAOYSA-N 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 230000036325 urinary excretion Effects 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyrane Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39524595A | 1995-02-27 | 1995-02-27 | |
| US395245 | 1995-02-27 | ||
| US08/476,946 US5866601A (en) | 1995-02-27 | 1995-06-06 | Carbocyclic compounds |
| US476946 | 1995-06-06 | ||
| US58056795A | 1995-12-29 | 1995-12-29 | |
| US580567 | 1995-12-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69635231D1 DE69635231D1 (de) | 2006-02-09 |
| DE69635231T2 true DE69635231T2 (de) | 2006-07-13 |
Family
ID=27410155
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69635231T Expired - Lifetime DE69635231T2 (de) | 1995-02-27 | 1996-02-26 | Selektive Inhibitoren viraler oder bakterieller Neuraminidase |
| DE0759917T Pending DE759917T1 (de) | 1995-02-27 | 1996-02-26 | Neue selektive inhibitoren viraler oder bakterieller neuraminidasen |
| DE69607704T Expired - Lifetime DE69607704T2 (de) | 1995-02-27 | 1996-02-26 | Neue selektive inhibitoren viraler oder bakterieller neuraminidasen |
| DE2002199052 Pending DE10299052I1 (de) | 1995-02-27 | 1996-02-26 | Neue selektive Inhibitoren viraler oder bakterieller Neuraminidasen |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE0759917T Pending DE759917T1 (de) | 1995-02-27 | 1996-02-26 | Neue selektive inhibitoren viraler oder bakterieller neuraminidasen |
| DE69607704T Expired - Lifetime DE69607704T2 (de) | 1995-02-27 | 1996-02-26 | Neue selektive inhibitoren viraler oder bakterieller neuraminidasen |
| DE2002199052 Pending DE10299052I1 (de) | 1995-02-27 | 1996-02-26 | Neue selektive Inhibitoren viraler oder bakterieller Neuraminidasen |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US5952375A (enExample) |
| EP (1) | EP0759917B1 (enExample) |
| JP (3) | JP3300365B2 (enExample) |
| KR (1) | KR100447096B1 (enExample) |
| CN (2) | CN1185223C (enExample) |
| AT (2) | ATE191711T1 (enExample) |
| AU (1) | AU720933B2 (enExample) |
| BR (2) | BR9607098A (enExample) |
| CZ (1) | CZ297945B6 (enExample) |
| DE (4) | DE69635231T2 (enExample) |
| DK (1) | DK0759917T3 (enExample) |
| ES (2) | ES2118674T3 (enExample) |
| GR (1) | GR3033914T3 (enExample) |
| HU (1) | HU228450B1 (enExample) |
| LU (1) | LU90991I2 (enExample) |
| MX (1) | MX9706496A (enExample) |
| NL (1) | NL300105I2 (enExample) |
| NO (1) | NO318455B1 (enExample) |
| NZ (1) | NZ306625A (enExample) |
| PL (1) | PL194173B1 (enExample) |
| PT (1) | PT759917E (enExample) |
| RU (1) | RU2181357C2 (enExample) |
| SG (1) | SG45864A1 (enExample) |
| SI (1) | SI9620042A (enExample) |
| UA (1) | UA56128C2 (enExample) |
| WO (1) | WO1996026933A1 (enExample) |
Families Citing this family (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG45864A1 (en) | 1995-02-27 | 1999-04-27 | Novel selective inhibitors of viral or bacterial neuraminidases | |
| US5714509A (en) * | 1995-05-03 | 1998-02-03 | The University Of Alabama | Inhibitors of bacterial sialidase and methods of making and using the same |
| US5763483A (en) * | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
| US6093816A (en) | 1996-06-27 | 2000-07-25 | Isis Pharmaceuticals, Inc. | Cationic lipids |
| DK0920410T3 (da) * | 1996-08-23 | 2002-06-10 | Gilead Sciences Inc | Fremgangsmåde til fremstilling af cyclohexencarboxylatderivater |
| US5859284A (en) * | 1996-08-23 | 1999-01-12 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| US6518438B2 (en) | 1996-08-23 | 2003-02-11 | Gilead Sciences, Inc. | Preparation of cyclohexene carboxylate derivatives |
| CN1238762A (zh) * | 1996-10-21 | 1999-12-15 | 吉里德科学公司 | 哌啶化合物 |
| US5994377A (en) | 1996-10-21 | 1999-11-30 | Gilead Sciences, Inc. | Piperidine compounds |
| JP3691075B2 (ja) * | 1996-11-14 | 2005-08-31 | バイオタ、サイアンティフィック、マネージメント、プロプライエタリ、リミテッド | 新規化合物およびその使用方法 |
| AU8673598A (en) * | 1997-08-01 | 1999-02-22 | University Of Florida | Neuraminidase inhibitors |
| US5886213A (en) * | 1997-08-22 | 1999-03-23 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| WO1999014185A1 (en) * | 1997-09-17 | 1999-03-25 | Gilead Sciences, Inc. | Compounds containing six-membered rings, processes for their preparation, and their use as medicaments |
| US20040053999A1 (en) * | 1997-09-17 | 2004-03-18 | Bischofberger Norbert W. | Novel compounds and methods for synthesis and therapy |
| TW477783B (en) * | 1997-12-12 | 2002-03-01 | Gilead Sciences Inc | Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same |
| ES2324746T3 (es) * | 1997-12-17 | 2009-08-13 | Biocryst Pharmaceuticals Inc. | Compuestos de ciclopentano y ciclopenteno sustituidos utiles como inhibidores de neuraminidasa. |
| US6518305B1 (en) | 1998-04-23 | 2003-02-11 | Abbott Laboratories | Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
| CN1328546A (zh) * | 1998-04-23 | 2001-12-26 | 艾博特公司 | 作为神经氨酸酶抑制剂的吡咯烷 |
| US6455571B1 (en) | 1998-04-23 | 2002-09-24 | Abbott Laboratories | Inhibitors of neuraminidases |
| ATE209621T1 (de) * | 1998-05-13 | 2001-12-15 | Hoffmann La Roche | Verfahren zur herstellung von shikiminsäure und deren derivate |
| WO2000029385A1 (en) * | 1998-11-13 | 2000-05-25 | Gilead Sciences, Inc. | 1,4,5,6-tetrahydro-pyridazine derivatives, their preparation and their use as neuraminidase inhibitors |
| AUPP913999A0 (en) * | 1999-03-12 | 1999-04-01 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| EP1059283B1 (en) * | 1999-06-11 | 2003-05-28 | F. Hoffmann-La Roche Ag | Process for preparing neuraminidase inhibitor ro-64-0796 |
| DE19930177B4 (de) | 1999-06-30 | 2007-02-08 | Nikolai Vladimirovich Bovin | Intermolekular assoziierende Verbindungen und deren Verwendung |
| US6593314B1 (en) * | 1999-10-19 | 2003-07-15 | Abbott Laboratories | Neuraminidase inhibitors |
| BR0010525A (pt) * | 1999-10-19 | 2002-11-26 | Abbott Lab | cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase |
| US6627396B1 (en) * | 1999-10-28 | 2003-09-30 | The Regents Of The University Of California | Influenza sensor |
| JP2001131144A (ja) | 1999-11-02 | 2001-05-15 | Sagami Chem Res Center | 7−アザビシクロ[4.1.0]ヘプト−3−エン−3−カルボン酸エステル類の製造方法 |
| US6462226B1 (en) | 1999-12-03 | 2002-10-08 | Hoffmann-La Roche Inc. | Process for the preparation of 4,5-diamino shikimic acid derivatives |
| EP1245569A1 (en) * | 1999-12-27 | 2002-10-02 | Sagami Chemical Research Center | Process for the production of 5-oxy-7-oxabicyclo- 4.1.0]hept-3-e ne-3-carboxylic acid esters |
| US8642051B2 (en) * | 2000-03-21 | 2014-02-04 | Suzanne Jaffe Stillman | Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s) |
| AU2001252578A1 (en) * | 2000-04-25 | 2001-11-07 | Sankyo Company Limited | Preventives for influenza |
| GB0015324D0 (en) * | 2000-06-22 | 2000-08-16 | Biota Scient Management | Medicaments |
| PT1296656E (pt) | 2000-06-27 | 2006-12-29 | Hoffmann La Roche | Processo para a preparação de uma composição |
| AUPR001000A0 (en) | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| WO2002092555A1 (en) * | 2001-05-11 | 2002-11-21 | Sankyo Company, Limited | Sialic acid derivatives |
| US6964784B2 (en) | 2002-03-07 | 2005-11-15 | Optigenex, Inc. | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
| RU2220739C1 (ru) * | 2002-08-30 | 2004-01-10 | Гапонюк Петр Яковлевич | Интраназальное средство |
| US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| US7122684B2 (en) | 2003-03-13 | 2006-10-17 | Roche Colorado Corporation | Process for preparing 1,2-diamino compounds |
| WO2004111064A1 (en) | 2003-06-16 | 2004-12-23 | Institute Of Organic Chemistry And Biochemistry, Academy Of Sciences Of The Czech Republic | Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs |
| WO2007053792A2 (en) * | 2005-11-05 | 2007-05-10 | Amplyx Pharmaceuticals, Inc. | Improving the pharmacokinetics of protease inhibitors and other drugs |
| ATE510813T1 (de) * | 2005-11-25 | 2011-06-15 | Hetero Drugs Ltd | Verbessertes verfahren für oseltamivirphosphat |
| KR100819759B1 (ko) | 2005-12-01 | 2008-04-07 | (주)파인켐 | 아자이드 화합물의 폭발성을 제거한 공정을 이용한 1,2-다이아미노 화합물 또는 이의 부가염 제조 방법 |
| EP2178819A2 (en) | 2005-12-28 | 2010-04-28 | F.Hoffmann-La Roche Ag | Epoxide intermediate in the tamiflu synthesis |
| SG183583A1 (en) | 2006-02-20 | 2012-09-27 | Chugai Pharmaceutical Co Ltd | Pharmaceutical composition comprising oseltamivir phosphate |
| US20080063722A1 (en) * | 2006-09-08 | 2008-03-13 | Advanced Inhalation Research, Inc. | Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) |
| US20080306098A1 (en) * | 2006-11-06 | 2008-12-11 | Mutz Mitchell W | Pharmacokinetics of protease inhibitors and other drugs |
| AU2008208865B2 (en) | 2007-01-23 | 2013-01-24 | Therapicon Srl | Antiviral compounds |
| US20080194801A1 (en) * | 2007-02-14 | 2008-08-14 | Swanson Basil I | Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses |
| EP2145010A1 (en) * | 2007-04-13 | 2010-01-20 | Monsanto Technology, LLC | Use of glyphosate to produce shikimic acid in microorganisms |
| US20090054334A1 (en) * | 2007-05-23 | 2009-02-26 | Mutz Mitchell W | Combinatorial improvement of bifunctional drug properties |
| US7888337B2 (en) | 2007-08-31 | 2011-02-15 | Academia Sinica | Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity |
| WO2009052303A2 (en) * | 2007-10-16 | 2009-04-23 | Monsanto Technology Llc | Processes for producing and recovering shikimic acid |
| WO2009055042A1 (en) * | 2007-10-24 | 2009-04-30 | Amplyx Pharmaceuticals, Inc. | Enhancing the efficacy of anti-infective therapeutics |
| WO2009078813A1 (en) * | 2007-12-19 | 2009-06-25 | Nanyang Technological University | Method of forming oseltamivir and derivatives thereof |
| US8334319B2 (en) * | 2008-01-04 | 2012-12-18 | Roche Palo Alto Llc | Polymorphic forms of oseltamivir phosphate |
| US20100081713A1 (en) * | 2008-03-19 | 2010-04-01 | CombinatoRx, (Singapore) Pte. Ltd. | Compositions and methods for treating viral infections |
| EP2276479B1 (en) | 2008-04-15 | 2014-07-02 | SineVir Therapeutics LLC | Prodrugs of neuraminidase inhibitors |
| TWI491416B (zh) | 2008-12-24 | 2015-07-11 | Daiichi Sankyo Co Ltd | 吸入用乾燥粉末醫藥組成物 |
| CN101486664B (zh) * | 2008-12-31 | 2013-09-04 | 北京大学深圳研究生院 | 用作流感病毒神经氨酸酶抑制剂的多取代五元环小分子化合物 |
| JP2012526793A (ja) | 2009-05-15 | 2012-11-01 | レッドエックス ファーマ リミテッド | 酸化還元薬物誘導体 |
| WO2011021223A2 (en) * | 2009-08-19 | 2011-02-24 | Msn Laboratories Limited | Novel salts of ethyl (3r, 4s, 5r)-4,5-imino-3-(l-ethylpropoxy)-1- cvclohexene-1-carboxylate and its use |
| JP5837502B2 (ja) * | 2009-11-11 | 2015-12-24 | スリーエム イノベイティブ プロパティズ カンパニー | ポリマー組成物並びにその製造方法及び物品 |
| IT1396620B1 (it) | 2009-11-25 | 2012-12-14 | Therapicon Srl | Analoghi chimerici |
| WO2012010276A1 (en) | 2010-07-16 | 2012-01-26 | Grindeks | Derivatives of 1,4-dihydropyridine possessing antiviral efficacy |
| AT510585B1 (de) | 2010-11-18 | 2012-05-15 | Apeptico Forschung & Entwicklung Gmbh | Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase |
| KR101369584B1 (ko) | 2011-04-19 | 2014-03-06 | 일양약품주식회사 | 페닐-이속사졸 유도체 및 그의 제조방법 |
| EP2578218A1 (en) | 2011-10-06 | 2013-04-10 | Grindeks, A Joint Stock Company | Antiviral efficacy of disodium 2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) and its derivatives |
| DE102011117128A1 (de) * | 2011-10-28 | 2013-05-02 | Christian-Albrechts-Universität Zu Kiel | Verbindungen zur Therapie der Influenza |
| RU2469020C1 (ru) * | 2011-11-08 | 2012-12-10 | Александр Васильевич Иващенко | (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения |
| RU2489422C1 (ru) * | 2012-05-12 | 2013-08-10 | Александр Васильевич Иващенко | Фторзамещенные (3r,4r,5s)-5-гуанидино-4-ациламино-3-(пентан-3-илокси)циклогексен-1-карбоновые кислоты, их эфиры и способ применения |
| RU2521593C1 (ru) * | 2013-02-27 | 2014-06-27 | Общество с ограниченной ответственностью "Интеллектуальный Диалог" | Моно и дифторзамещенные этил (3r,4r,5s)-5-азидо-4-ацетиламино-3-(1-этилпропокси)-циклогексен-1-карбоксилаты, способ получения и применения |
| JP6453050B2 (ja) * | 2013-11-15 | 2019-01-16 | 国立大学法人富山大学 | 2−デオキシ−2,3−ジデヒドロシアル酸誘導体およびその製造法 |
| CN103819357B (zh) * | 2014-01-28 | 2016-03-16 | 浙江大学 | (-)-有效霉醇叠氮四乙酸酯的制备方法 |
| EP3106455A4 (en) * | 2014-02-14 | 2017-09-27 | TOA Eiyo Ltd. | Cyclic hydrocarbon compound |
| CA2948441A1 (en) | 2014-05-12 | 2015-11-19 | Glaxosmithkline Intellectual Property (No. 2) Limited | Pharmaceutical compositions for treating infectious diseases |
| US9392814B2 (en) | 2014-06-06 | 2016-07-19 | Nicholas J. Singer | Delivery system for drinks |
| GB2532178A (en) * | 2014-06-09 | 2016-05-18 | Redx Pharma Plc | Antiviral compounds |
| CN107427529A (zh) | 2014-12-26 | 2017-12-01 | 埃莫里大学 | N4‑羟基胞苷和衍生物及与其相关的抗病毒用途 |
| USD773313S1 (en) | 2015-06-23 | 2016-12-06 | Nicholas J. Singer | Package |
| WO2017106820A1 (en) | 2015-12-17 | 2017-06-22 | Thomas Jefferson University | Antiviral agents for drug-resistant influenza a |
| KR102339817B1 (ko) | 2016-06-30 | 2021-12-16 | 한미약품 주식회사 | 오셀타미비어 함유 경구용 고형제제 및 그 제조방법 |
| CR20190123A (es) * | 2016-08-10 | 2019-04-30 | Shionogi & Co | Composiciones farmacéuticas que contienen derivados de piridona policíclicos sustituídos y profármacos de los mismos |
| ES2995458T3 (en) | 2017-12-07 | 2025-02-10 | Univ Emory | N4-hydroxycytidine derivative and anti-viral uses related thereto |
| KR20200106607A (ko) | 2019-03-05 | 2020-09-15 | 주식회사 코아팜바이오 | 오셀타미비르 함유 의약 조성물 |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968788A (en) * | 1986-04-04 | 1990-11-06 | Board Of Regents, The University Of Texas System | Biologically reversible phosphate and phosphonate protective gruops |
| US5206400A (en) * | 1986-07-07 | 1993-04-27 | Ohio State University | Diastereomeric mono- and di-substituted diamino cyclohexane compounds and the method of preparation thereof |
| AU2947889A (en) * | 1988-01-12 | 1989-08-11 | Board Of Regents, The University Of Texas System | Histamine release inhibitory factor and preparations therefore |
| US5175273A (en) * | 1988-07-01 | 1992-12-29 | Genentech, Inc. | Nucleic acid intercalating agents |
| US5270340A (en) * | 1988-12-27 | 1993-12-14 | Bayer Aktiengesellschaft | Substituted 2-cyclohexen-1-yl-amine fungicidal and herbicidal agents |
| GB2238049A (en) * | 1989-11-22 | 1991-05-22 | Ki Nii Epidemiologii I Infekts | Method for preparing inhibitor for influenza virus neuraminidase |
| SK282950B6 (sk) * | 1990-04-24 | 2003-01-09 | Biota Scientific Management Pty Ltd | Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze |
| WO1992006691A1 (en) * | 1990-10-19 | 1992-04-30 | Biota Scientific Management Pty. Ltd. | Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus |
| DE4033415A1 (de) * | 1990-10-20 | 1992-04-23 | Bayer Ag | Antimikrobielle mittel sowie substituierte 2-cyclohexan-1-yl-amin-derivate und deren herstellung |
| DE4131311A1 (de) * | 1991-09-20 | 1993-04-01 | Basf Ag | Dihydropyranderivate und diese enthaltende pflanzenschutzmittel |
| CA2081068C (en) * | 1991-10-23 | 2005-11-29 | Laurence Mark Von Itzstein | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid |
| GB9126725D0 (en) * | 1991-12-17 | 1992-02-12 | Glaxo Group Ltd | Process |
| FR2687674B1 (fr) * | 1992-02-07 | 1995-05-19 | Roussel Uclaf | Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
| US5292938A (en) * | 1992-04-13 | 1994-03-08 | Associated Universities, Inc. | Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging |
| US5633360A (en) | 1992-04-14 | 1997-05-27 | Gilead Sciences, Inc. | Oligonucleotide analogs capable of passive cell membrane permeation |
| GB9220241D0 (en) * | 1992-09-25 | 1992-11-11 | Glaxo Group Ltd | Process |
| GB9220327D0 (en) * | 1992-09-25 | 1992-11-11 | Glaxo Group Ltd | Process |
| US5639786A (en) * | 1992-12-04 | 1997-06-17 | Biota Scientific Management, Pty., Ltd. | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid |
| US5514798A (en) * | 1993-06-02 | 1996-05-07 | Gilead Sciences, Inc. | Method and cyclic carbonates for nucleotide analogues |
| GB9311873D0 (en) * | 1993-06-09 | 1993-07-28 | Glaxo Group Ltd | Process |
| GB9311892D0 (en) * | 1993-06-09 | 1993-07-28 | Glaxo Wellcome Australia Ltd | Device |
| GB9312531D0 (en) * | 1993-06-17 | 1993-08-04 | Glaxo Group Ltd | Process |
| GB9325841D0 (en) * | 1993-12-17 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
| GB9400206D0 (en) * | 1994-01-07 | 1994-03-02 | Glaxo Group Ltd | Chemical compound |
| AUPM354694A0 (en) * | 1994-01-27 | 1994-02-17 | Biota Scientific Management Pty Ltd | Chemical compounds |
| US5985859A (en) * | 1994-04-14 | 1999-11-16 | The University Of Alabama | Methods of inhibiting bacterial sialidase |
| GB9410817D0 (en) * | 1994-05-28 | 1994-07-20 | Glaxo Group Ltd | Medicaments |
| AUPM725794A0 (en) * | 1994-08-03 | 1994-08-25 | Biota Scientific Management Pty Ltd | Chemical compounds |
| US5556963A (en) * | 1994-08-05 | 1996-09-17 | Oklahoma Medical Research Foundation | Synthesis of 4-alkoxy-N-acetylneuraminic acid |
| GB9416365D0 (en) * | 1994-08-12 | 1994-10-05 | Glaxo Group Ltd | Medicaments |
| US5512596A (en) * | 1994-09-02 | 1996-04-30 | Gilead Sciences, Inc. | Aromatic compounds |
| AU710492B2 (en) | 1994-11-04 | 1999-09-23 | Gilead Sciences, Inc. | Thiepane compounds inhibiting and detecting HIV protease |
| US5866601A (en) * | 1995-02-27 | 1999-02-02 | Gilead Sciences, Inc. | Carbocyclic compounds |
| SG45864A1 (en) * | 1995-02-27 | 1999-04-27 | Novel selective inhibitors of viral or bacterial neuraminidases | |
| US5602277A (en) * | 1995-03-30 | 1997-02-11 | Biocryst Pharmaceuticals, Inc. | Substituted benzene derivatives useful as neuraminidase inhibitors |
| US5714509A (en) | 1995-05-03 | 1998-02-03 | The University Of Alabama | Inhibitors of bacterial sialidase and methods of making and using the same |
| GB9510141D0 (en) | 1995-05-19 | 1995-07-12 | Biota Scient Management | Chemical compounds |
| GB9525389D0 (en) | 1995-12-12 | 1996-02-14 | Biota Scient Management Ltd | Chemical compounds |
| DE69615555T2 (de) * | 1995-05-19 | 2002-05-29 | Biota Scientific Management Pty. Ltd., Melbourne | 6-carboxamido-dihydropyran-derivate |
| GB9516276D0 (en) * | 1995-08-08 | 1995-10-11 | Biota Scient Management | Chemical compounds |
| US5763483A (en) * | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
| US5859284A (en) | 1996-08-23 | 1999-01-12 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| DK0920410T3 (da) | 1996-08-23 | 2002-06-10 | Gilead Sciences Inc | Fremgangsmåde til fremstilling af cyclohexencarboxylatderivater |
| US5948816A (en) * | 1996-09-10 | 1999-09-07 | Daikin Industries, Ltd. | 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds |
| US5886213A (en) | 1997-08-22 | 1999-03-23 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
-
1996
- 1996-02-26 SG SG1997004840A patent/SG45864A1/en unknown
- 1996-02-26 DE DE69635231T patent/DE69635231T2/de not_active Expired - Lifetime
- 1996-02-26 BR BR9607098A patent/BR9607098A/pt not_active IP Right Cessation
- 1996-02-26 SI SI9620042A patent/SI9620042A/sl not_active IP Right Cessation
- 1996-02-26 DE DE0759917T patent/DE759917T1/de active Pending
- 1996-02-26 AU AU53571/96A patent/AU720933B2/en not_active Expired
- 1996-02-26 MX MX9706496A patent/MX9706496A/es unknown
- 1996-02-26 WO PCT/US1996/002882 patent/WO1996026933A1/en not_active Ceased
- 1996-02-26 PT PT96912404T patent/PT759917E/pt unknown
- 1996-02-26 DE DE69607704T patent/DE69607704T2/de not_active Expired - Lifetime
- 1996-02-26 ES ES96912404T patent/ES2118674T3/es not_active Expired - Lifetime
- 1996-02-26 HU HU9800026A patent/HU228450B1/hu unknown
- 1996-02-26 KR KR1019970705932A patent/KR100447096B1/ko not_active Expired - Lifetime
- 1996-02-26 US US08/606,624 patent/US5952375A/en not_active Expired - Lifetime
- 1996-02-26 AT AT96912404T patent/ATE191711T1/de active
- 1996-02-26 CN CNB961901330A patent/CN1185223C/zh not_active Expired - Lifetime
- 1996-02-26 CZ CZ0269097A patent/CZ297945B6/cs not_active IP Right Cessation
- 1996-02-26 JP JP52644296A patent/JP3300365B2/ja not_active Expired - Lifetime
- 1996-02-26 DK DK96912404T patent/DK0759917T3/da active
- 1996-02-26 DE DE2002199052 patent/DE10299052I1/de active Pending
- 1996-02-26 RU RU97116714/04A patent/RU2181357C2/ru active
- 1996-02-26 NZ NZ306625A patent/NZ306625A/xx not_active IP Right Cessation
- 1996-02-26 EP EP96912404A patent/EP0759917B1/en not_active Expired - Lifetime
- 1996-02-26 PL PL96322000A patent/PL194173B1/pl unknown
- 1996-02-26 CN CNB011247142A patent/CN100409844C/zh not_active Expired - Lifetime
- 1996-02-26 BR BRPI9607098-6B8D patent/BR9607098B8/pt unknown
- 1996-02-26 UA UA97094796A patent/UA56128C2/uk unknown
- 1996-02-26 AT AT99117934T patent/ATE305453T1/de active
- 1996-02-26 ES ES99117934T patent/ES2249863T3/es not_active Expired - Lifetime
- 1996-05-24 US US08/653,034 patent/US20050176758A1/en not_active Abandoned
-
1997
- 1997-08-26 NO NO19973908A patent/NO318455B1/no not_active IP Right Cessation
-
1999
- 1999-04-08 US US09/288,091 patent/US6225341B1/en not_active Expired - Lifetime
-
2000
- 2000-07-07 GR GR20000401599T patent/GR3033914T3/el unknown
-
2001
- 2001-08-24 JP JP2001255372A patent/JP4234917B2/ja not_active Expired - Lifetime
-
2002
- 2002-10-29 NL NL300105C patent/NL300105I2/nl unknown
- 2002-12-11 LU LU90991C patent/LU90991I2/fr unknown
-
2005
- 2005-07-15 JP JP2005207906A patent/JP2006036770A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69635231T2 (de) | Selektive Inhibitoren viraler oder bakterieller Neuraminidase | |
| DE69735634T2 (de) | Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind | |
| DE69813616T2 (de) | Cyclohexencarboxylate als inhibitoren der neuraminidase | |
| EP0133674B1 (de) | Neue Nitroxylverbindungen, Verfahren zu deren Herstellung und diese enthaltende diagnostische Mittel | |
| AU747702B2 (en) | Compounds containing six-membered rings, processes for their preparation, and their use as medicaments | |
| DE69229557T2 (de) | Neue sphingoglycolipide und verwendung davon | |
| DE3241399C2 (enExample) | ||
| JP2002521312A (ja) | ノイラミニダーゼの阻害剤 | |
| EP0976734B1 (en) | Selective inhibitors of viral or bacterial neuraminidase | |
| DE69004143T2 (de) | 6-Fluorshikiminsäurederivate. | |
| DE3784772T2 (de) | Verfahren zur herstellung von 7-oxabicycloheptan-aminoalkohol-zwischenprodukten zur verwendung in der herstellung von thromboxan-a2-antagonisten und zwischenprodukte in diesem verfahren. | |
| DE3132221A1 (de) | Neue cyclophosphamid-derivate, verfahren zu ihrer herstellung und ihre verwendung | |
| DE69202075T2 (de) | Polyhydroxycyclopentan Derivate, ihre Herstellung und ihre therapeutische Verwendung. | |
| DE19801646A1 (de) | Substituierte alpha,beta-annellierte Butyrolactone | |
| SU1217261A3 (ru) | Способ получени 6-(2-амино-2-фенилацетамидо)пеницилланоилоксиметил-1,1-диоксопеницилланоилметилкарбоната или его кислотно-аддитивной соли | |
| EP0367205B1 (de) | 2-Aminocarbonsäuren und deren Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel | |
| EP0564658B1 (en) | 2-(2,3-dicarboxycyclopropyl)glycine and method for producing the same | |
| JPH05213957A (ja) | 新規なスピロピロリジンイミダゾリン誘導体および新規なアミノピロリジンカルボン酸誘導体並びに該化合物を有効成分とする鎮けい剤 | |
| AU2003204079B2 (en) | Novel compounds and methods for synthesis and therapy | |
| HK1026893B (en) | Selective inhibitors of viral or bacterial neuraminidase | |
| DE60214412T2 (de) | Simplifizierte sarcodictyn-derivate als anti-tumor-mittel | |
| EP0026611A1 (en) | Antibacterial sulphonamides, processes for their preparation and compositions containing them | |
| DE102011088854B4 (de) | Verfahren zur Herstellung von Sphingosin-1-phosphat | |
| CA2246054A1 (en) | 2,3-disubstituted cyclopentanone derivatives, process for producing the same, and medicinal use thereof | |
| HK1120494B (en) | Novel compounds and methods for synthesis and therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |